| NCT04244591 |
Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04252118 |
Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04251871 |
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04251871 |
| NCT04252274 |
Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04252885 |
The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04257656 |
A Trial of Remdesivir in Adults With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04257656 |
| NCT04263402 |
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04255017 |
A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04254874 |
A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04264533 |
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia |
https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04261270 |
A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04331613 |
Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS |
https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04275245 |
Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia |
https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04261517 |
Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04269525 |
Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia |
https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04282902 |
A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection |
https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04276688 |
Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment |
https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04280224 |
NK Cells Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04304313 |
A Pilot Study of Sildenafil in COVID-19 |
https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04275414 |
Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04273763 |
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04645407 |
Effects of Fuzheng Huayu Tablets on COVID-19 |
https://ClinicalTrials.gov/show/NCT04645407 |
| NCT04279197 |
Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu |
https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04273321 |
Efficacy and Safety of Corticosteroids in COVID-19 |
https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04276987 |
A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia |
https://ClinicalTrials.gov/show/NCT04276987 |
| NCT04276896 |
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine |
https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04343794 |
Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 |
https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04280705 |
Adaptive COVID-19 Treatment Trial (ACTT) |
https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04283461 |
Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04303299 |
Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04303299 |
| NCT04288102 |
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04291729 |
Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04292899 |
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04292730 |
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment |
https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04296643 |
Medical Masks vs N95 Respirators for COVID-19 |
https://ClinicalTrials.gov/show/NCT04296643 |
| NCT04308317 |
Tetrandrine Tablets Used in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04304053 |
Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention |
https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04299724 |
Safety and Immunity of Covid-19 aAPC Vaccine |
https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04303507 |
Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting |
https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04306055 |
Blood Donor Recruitment During Epidemic of COVID-19 |
https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04310228 |
Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04305457 |
Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04305106 |
Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT |
https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 |
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic |
https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04307693 |
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04307693 |
| NCT04306393 |
Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 |
https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04308668 |
Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04316377 |
Norwegian Coronavirus Disease 2019 Study |
https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04315948 |
Trial of Treatments for COVID-19 in Hospitalized Adults |
https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04311177 |
Losartan for Patients With COVID-19 Not Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04312009 |
Losartan for Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04315480 |
Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis |
https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04311697 |
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04315298 |
Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04313322 |
Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04313127 |
Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults |
https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04312243 |
NO Prevention of COVID-19 for Healthcare Providers |
https://ClinicalTrials.gov/show/NCT04312243 |
| NCT04313023 |
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04312997 |
The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04323514 |
Use of Ascorbic Acid in Patients With COVID 19 |
https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04321174 |
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir |
https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04315896 |
Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04323527 |
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 |
https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04320056 |
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04318015 |
Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) |
https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04317092 |
Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) |
https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04317040 |
CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04324606 |
A Study of a Candidate COVID-19 Vaccine (COV001) |
https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04321928 |
Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary |
https://ClinicalTrials.gov/show/NCT04321928 |
| NCT04319900 |
Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia |
https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04319445 |
Mindfulness During COVID-19 |
https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04318444 |
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04318431 |
Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children |
https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04325867 |
Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04320953 |
Non-contact Endoscopy at Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04320238 |
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff |
https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319731 |
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04328961 |
Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) |
https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04328129 |
Household Transmission Investigation Study for COVID-19 in Tropical Regions |
https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04323345 |
Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus |
https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04323228 |
Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04323228 |
| NCT04322682 |
Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) |
https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322396 |
Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04322344 |
Escin in Patients With Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04321616 |
The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients |
https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04321421 |
Hyperimmune Plasma for Critical Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04321278 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) |
https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04321096 |
The Impact of Camostat Mesilate on COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04320615 |
A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04330690 |
Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial |
https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04327349 |
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial |
https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04323800 |
Convalescent Plasma to Stem Coronavirus (CSSC-001) |
https://ClinicalTrials.gov/show/NCT04323800 |
| NCT04322773 |
Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04322565 |
Colchicine Counteracting Inflammation in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04322123 |
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04321993 |
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04326920 |
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) |
https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04371601 |
Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04353271 |
Trial of Hydroxychloroquine In Covid-19 Kinetics |
https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04336462 |
Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04328285 |
Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04327206 |
BCG Vaccination to Protect Healthcare Workers Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04326452 |
Treating COVID-19 With a Bidirectional Oxygenation Valve |
https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04325893 |
Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease |
https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04324996 |
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 |
https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324528 |
Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 |
DAS181 for Severe COVID-19: Compassionate Use |
https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324463 |
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial |
https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04324073 |
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI |
https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324021 |
Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04327505 |
Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04329533 |
Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04327401 |
COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III |
https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04327388 |
Sarilumab COVID-19 |
https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04326790 |
The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention |
https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04326426 |
ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04326036 |
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04325906 |
Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS |
https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04324190 |
DIgital Online SuPport for COVID-19 StrEss |
https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04355962 |
Sevoflurane in COVID-19 ARDS (SevCov) |
https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04331899 |
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04328493 |
The Vietnam Chloroquine Treatment on COVID-19 |
https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04328467 |
Pre-exposure Prophylaxis for SARS-Coronavirus-2 |
https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 |
Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine |
https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328012 |
COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04336254 |
Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04329195 |
ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic |
https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04331054 |
Protective Role of Inhaled Steroids for Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04329611 |
ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease |
https://ClinicalTrials.gov/show/NCT04329611 |
| NCT04333368 |
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS |
https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04348370 |
BCG Vaccine for Health Care Workers as Defense Against COVID 19 |
https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04332380 |
Convalescent Plasma for Patients With COVID-19: A Pilot Study |
https://ClinicalTrials.gov/show/NCT04332380 |
| NCT04332081 |
Hyperbaric Oxygen for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04332081 |
| NCT04331600 |
Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 |
https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04331470 |
Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04329832 |
Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04328480 |
The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04332107 |
Azithromycin for COVID-19 Treatment in Outpatients Nationwide |
https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04329923 |
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) |
https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04376515 |
Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) |
https://ClinicalTrials.gov/show/NCT04376515 |
| NCT04352348 |
Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being |
https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04343651 |
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04342182 |
Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) |
https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04336332 |
Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04335305 |
Checkpoint Blockade in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04335123 |
Study of Open Label Losartan in COVID-19 |
https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04334980 |
Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04334980 |
| NCT04333732 |
CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION |
https://ClinicalTrials.gov/show/NCT04333732 |
| NCT04333355 |
Safety in Convalescent Plasma Transfusion to COVID-19 |
https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04332991 |
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease |
https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04332835 |
Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study |
https://ClinicalTrials.gov/show/NCT04332835 |
| NCT04332094 |
Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04331808 |
CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) |
https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04331366 |
Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 |
https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04330586 |
A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04330586 |
| NCT04329650 |
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04347174 |
A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04330638 |
Treatment of COVID-19 Patients With Anti-interleukin Drugs |
https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04339712 |
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction |
https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04338009 |
Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04337996 |
Dynamic Evaluation of COVID-19 Diagnostic Tests |
https://ClinicalTrials.gov/show/NCT04337996 |
| NCT04335136 |
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335097 |
Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation |
https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04334265 |
Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 |
https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04334044 |
Treatment of SARS Caused by COVID-19 With Ruxolitinib |
https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04333654 |
Hydroxychloroquine in Outpatient Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04333654 |
| NCT04333628 |
Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 |
https://ClinicalTrials.gov/show/NCT04333628 |
| NCT04333589 |
Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive |
https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333550 |
Application of Desferal to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333407 |
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. |
https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04333225 |
Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04331795 |
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis |
https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04335279 |
Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program |
https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04333914 |
Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04333914 |
| NCT04333420 |
Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04347226 |
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04345523 |
Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04340349 |
Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals |
https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04339660 |
Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04337541 |
Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System |
https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04335851 |
Video-Based Exercises and Well-Being During Social Isolation |
https://ClinicalTrials.gov/show/NCT04335851 |
| NCT04335786 |
Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease |
https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335084 |
A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04335084 |
| NCT04335071 |
Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334928 |
Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel |
https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04334850 |
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334629 |
LIBERATE Trial in COVID-19 |
https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04334512 |
A Study of Quintuple Therapy to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04334512 |
| NCT04334460 |
Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects |
https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04334382 |
Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 |
https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04348409 |
Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04343053 |
Pro-thrombotic Status in Patients With SARS-Cov-2 Infection |
https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04340544 |
Hydroxychloroquine for the Treatment of Mild COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04337008 |
Renin Angiotensin System - CoronaVirus |
https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04336904 |
Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 |
https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04336410 |
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04335552 |
Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04342650 |
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04341116 |
Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04338698 |
Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT |
https://ClinicalTrials.gov/show/NCT04338698 |
| NCT04338568 |
Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study |
https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04345861 |
Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) |
https://ClinicalTrials.gov/show/NCT04345861 |
| NCT04343092 |
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management |
https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04341675 |
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04338841 |
HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04338828 |
Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED |
https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04349631 |
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04346797 |
CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort |
https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04344951 |
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04340557 |
Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04339816 |
Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial |
https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04338074 |
TXA and Corona Virus 2019 (COVID19) in Outpatients |
https://ClinicalTrials.gov/show/NCT04338074 |
| NCT04337918 |
Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04384380 |
Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04364893 |
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04353674 |
Modulation of Hyperinflammation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04352933 |
PROLIFIC ChemoprophylaxisTrial (COVID-19) |
https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04347031 |
A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346147 |
Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 |
https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04345848 |
Preventing COVID-19 Complications With Low- and High-dose Anticoagulation |
https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04345614 |
A Study of Auxora in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04344210 |
Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04342169 |
University of Utah COVID-19 Hydrochloroquine Trial |
https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341922 |
A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04341493 |
Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341415 |
Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome |
https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341389 |
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) |
https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341038 |
Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury |
https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04340050 |
COVID-19 Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04338958 |
Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation |
https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04339426 |
Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04341441 |
Will Hydroxychloroquine Impede or Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04358081 |
Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04350580 |
Polyvalent Immunoglobulin in COVID-19 Related ARds |
https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04348383 |
Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. |
https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04347941 |
Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE |
https://ClinicalTrials.gov/show/NCT04347941 |
| NCT04347681 |
Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04346693 |
An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 |
https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346420 |
Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 |
https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04345653 |
Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04344457 |
Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04344236 |
Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04344236 |
| NCT04344106 |
Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04343768 |
An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343261 |
Convalescent Plasma in the Treatment of COVID 19 |
https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04343248 |
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) |
https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04342728 |
Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation |
https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04342689 |
The Role of Resistant Starch in COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04342689 |
| NCT04342663 |
A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04342221 |
Hydroxychloroquine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04341207 |
Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients |
https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04341142 |
Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER |
https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04343755 |
Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04344587 |
Awake Prone Position for Early Hypoxemia in COVID-19 |
https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04353037 |
PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine |
https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04351906 |
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04348513 |
Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04347980 |
Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 |
https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04346615 |
Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen |
https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04346589 |
Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04346199 |
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. |
https://ClinicalTrials.gov/show/NCT04346199 |
| NCT04345692 |
A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04344730 |
Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04344431 |
Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344080 |
Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344041 |
COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) |
https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04344015 |
COVID-19 Plasma Collection |
https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04343989 |
A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343963 |
Pyridostigmine in Severe SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04343729 |
Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 |
https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04343976 |
Pegylated Interferon Lambda Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04343976 |
| NCT04438850 |
COVidIVERmectin: Ivermectin for Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04438850 |
| NCT04390178 |
Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04357444 |
Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04357444 |
| NCT04351724 |
Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) |
https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04348929 |
Birth Experience During COVID-19 Confinement |
https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04346628 |
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04346628 |
| NCT04345991 |
Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort |
https://ClinicalTrials.gov/show/NCT04345991 |
| NCT04345549 |
Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04345289 |
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 |
Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04344600 |
Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04344561 |
Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation |
https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04344535 |
Convalescent Plasma vs. Standard Plasma for COVID-19 |
https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344444 |
Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease |
https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344288 |
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection |
https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04342897 |
A Study of LY3127804 in Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04351789 |
Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark |
https://ClinicalTrials.gov/show/NCT04351789 |
| NCT04349410 |
The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol |
https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04348305 |
Hydrocortisone for COVID-19 and Severe Hypoxia |
https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04347538 |
Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04347538 |
| NCT04347382 |
Honey & Nigella Sativa Trial Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04356495 |
Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation |
https://ClinicalTrials.gov/show/NCT04356495 |
| NCT04345419 |
Remdesivir vs Chloroquine in Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04345419 |
| NCT04463433 |
Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China |
https://ClinicalTrials.gov/show/NCT04463433 |
| NCT04349592 |
Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19 |
https://ClinicalTrials.gov/show/NCT04349592 |
| NCT04349371 |
Saved From COVID-19 |
https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04346355 |
Efficacy of Early Administration of Tocilizumab in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04346355 |
| NCT04360824 |
Covid-19 Associated Coagulopathy |
https://ClinicalTrials.gov/show/NCT04360824 |
| NCT04359251 |
Different PEEP Settings of COVID-19 Induced ARDS |
https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04357340 |
The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04355728 |
Use of UC-MSCs for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04354155 |
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial |
https://ClinicalTrials.gov/show/NCT04354155 |
| NCT04350281 |
Double Therapy With IFN-beta 1b and Hydroxychloroquine |
https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04349241 |
Efficacy and Safety of Favipiravir in Management of COVID-19 |
https://ClinicalTrials.gov/show/NCT04349241 |
| NCT04348695 |
Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. |
https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348656 |
CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) |
https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04348500 |
Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease |
https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04347954 |
PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19) |
https://ClinicalTrials.gov/show/NCT04347954 |
| NCT04347239 |
Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04346667 |
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds |
https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346017 |
Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome |
https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04348864 |
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care |
https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04498936 |
Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04498936 |
| NCT04382391 |
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04361916 |
Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) |
https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04357808 |
Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) |
https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04357106 |
COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma |
https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04356833 |
Nebulised Rt-PA for ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04356833 |
| NCT04355143 |
Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) |
https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04354831 |
A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 |
Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04353596 |
Stopping ACE-inhibitors in COVID-19 |
https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04352608 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04351763 |
Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms |
https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04351620 |
High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351581 |
Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04351542 |
Ayurveda for Flu Like Illness During Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351191 |
PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds |
https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04350736 |
First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350723 |
Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04350723 |
| NCT04350684 |
Umifenovir in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 |
Interferon Beta 1a in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350593 |
Dapagliflozin in Respiratory Failure in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04350320 |
Trial to Study the Benefit of Colchicine in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04349098 |
Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04348435 |
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04347915 |
The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04346446 |
Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04359095 |
Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia |
https://ClinicalTrials.gov/show/NCT04359095 |
| NCT04357327 |
Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04356534 |
Convalescent Plasma Trial in COVID -19 Patients |
https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04355897 |
CoVID-19 Plasma in Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355637 |
Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355026 |
Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04352959 |
COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses |
https://ClinicalTrials.gov/show/NCT04352959 |
| NCT04351516 |
Test and Treat COVID 65plus+ |
https://ClinicalTrials.gov/show/NCT04351516 |
| NCT04351347 |
The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04351347 |
| NCT04351295 |
Efficacy of Faviprevir in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04351295 |
| NCT04351152 |
Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04359290 |
Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS |
https://ClinicalTrials.gov/show/NCT04359290 |
| NCT04355364 |
Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) |
https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04353336 |
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04353336 |
| NCT04351243 |
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE) |
https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04367662 |
Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 |
https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04361838 |
The COVID-19 ICU PRAYER Study |
https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04361344 |
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04359264 |
Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04358939 |
Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) |
https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04358549 |
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04358406 |
Rhu-pGSN for Severe Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04358406 |
| NCT04354870 |
COVID-19 PrEP HCW HCQ Study |
https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04354428 |
Treatment for COVID-19 in High-Risk Adult Outpatients |
https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04354259 |
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 |
https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04353284 |
Camostat Mesylate in COVID-19 Outpatients |
https://ClinicalTrials.gov/show/NCT04353284 |
| NCT04353206 |
Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04353128 |
Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. |
https://ClinicalTrials.gov/show/NCT04353128 |
| NCT04352751 |
Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 |
https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04419610 |
RAS and Coagulopathy in COVID19 |
https://ClinicalTrials.gov/show/NCT04419610 |
| NCT04375774 |
Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE) |
https://ClinicalTrials.gov/show/NCT04375774 |
| NCT04373044 |
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04361942 |
Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) |
https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04359953 |
Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04359953 |
| NCT04357782 |
Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation |
https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04356690 |
Etoposide in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04356482 |
CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 |
https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04355936 |
Telmisartan for Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04355533 |
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19 |
https://ClinicalTrials.gov/show/NCT04355533 |
| NCT04355351 |
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19) |
https://ClinicalTrials.gov/show/NCT04355351 |
| NCT04355247 |
Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm |
https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04355234 |
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns |
https://ClinicalTrials.gov/show/NCT04355234 |
| NCT04363853 |
Tocilizumab Treatment in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04355767 |
Convalescent Plasma in Outpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04355767 |
| NCT04377308 |
Fluoxetine to Reduce Intubation and Death After COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04357730 |
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04385771 |
Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation |
https://ClinicalTrials.gov/show/NCT04385771 |
| NCT04376034 |
Convalescent Plasma Collection and Treatment in Pediatrics and Adults |
https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04363814 |
Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04363814 |
| NCT04358614 |
Baricitinib Therapy in COVID-19 |
https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04357028 |
Measles Vaccine in HCW |
https://ClinicalTrials.gov/show/NCT04357028 |
| NCT04356937 |
Efficacy of Tocilizumab on Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04356937 |
| NCT04534673 |
Pegylated Interferon Lambda for Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04534673 |
| NCT04374149 |
Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS |
https://ClinicalTrials.gov/show/NCT04374149 |
| NCT04374084 |
Moxibustion Plus Cupping in Convalescent Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04368845 |
Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study |
https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04368156 |
Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04366063 |
Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04364763 |
A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) |
https://ClinicalTrials.gov/show/NCT04364763 |
| NCT04362332 |
Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04362332 |
| NCT04362085 |
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care |
https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04362059 |
A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04362059 |
| NCT04359901 |
Sarilumab for Patients With Moderate COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04359680 |
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359537 |
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 |
https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04359277 |
A Randomized Trial of Anticoagulation Strategies in COVID-19 |
https://ClinicalTrials.gov/show/NCT04359277 |
| NCT04358068 |
Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 |
https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04358003 |
Plasma Adsorption in Patients With Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04357990 |
Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357457 |
Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia |
https://ClinicalTrials.gov/show/NCT04357457 |
| NCT04357366 |
suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) |
https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04359797 |
COVID-19 Patient Positioning Pragmatic Trial |
https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04413864 |
Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 |
https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04363736 |
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04363385 |
Collection of Biological Samples With Clinical Characterization of Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04363385 |
| NCT04362189 |
Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04362189 |
| NCT04362111 |
Early Treatment of Cytokine Storm Syndrome in Covid-19 |
https://ClinicalTrials.gov/show/NCT04362111 |
| NCT04361526 |
Pilot Study on Cytokine Filtration in COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04360551 |
Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04360551 |
| NCT04359862 |
Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 |
Plasma Therapy of COVID-19 in Severely Ill Patients |
https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359654 |
Nebulised Dornase Alfa for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04359654 |
| NCT04359329 |
Estrogen Patch for COVID-19 Symptoms |
https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04358926 |
Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) |
https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04358783 |
Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia |
https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04362176 |
Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults |
https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04373200 |
Human Ab Response & immunoMONItoring of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04366882 |
Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366245 |
Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04366089 |
Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora |
https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04365101 |
Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04364737 |
CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04364594 |
COVID-19 Search in Conjunctival Cells |
https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04363463 |
Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress |
https://ClinicalTrials.gov/show/NCT04363463 |
| NCT04362137 |
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) |
https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04361474 |
Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity |
https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361214 |
Leflunomide in Mild COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04360980 |
The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04360837 |
PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360811 |
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04366323 |
Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04361396 |
Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04377750 |
The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation |
https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04368377 |
Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04366947 |
Intravascular Access in Suspected/Confirmed COVID-19 Patient |
https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366297 |
Intravascular Access of COVID-19 Patient Under Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366271 |
Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04366271 |
| NCT04364022 |
Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland |
https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04363541 |
Local Thermotherapy for Patients With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04363541 |
| NCT04363528 |
Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU |
https://ClinicalTrials.gov/show/NCT04363528 |
| NCT04363502 |
Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04363450 |
Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) |
https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 |
COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363346 |
Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia |
https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04361253 |
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy |
https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04393961 |
At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study |
https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04385095 |
Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04372979 |
Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04372979 |
| NCT04372589 |
Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) |
https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04369378 |
Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04369378 |
| NCT04368988 |
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant |
https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368923 |
Management of Covid-19 Patients During Home Isolation |
https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368260 |
Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04367168 |
Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04366960 |
Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04366791 |
Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04366791 |
| NCT04366141 |
COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box |
https://ClinicalTrials.gov/show/NCT04366141 |
| NCT04366050 |
Ramipril for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04366050 |
| NCT04365972 |
Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic |
https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04365608 |
Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365309 |
Protective Effect of Aspirin on COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365153 |
Canakinumab in Covid-19 Cardiac Injury (The Three C Study) |
https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04365127 |
Progesterone for the Treatment of COVID-19 in Hospitalized Men |
https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04363827 |
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04363606 |
Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability |
https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04363372 |
A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04363372 |
| NCT04368000 |
Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04362813 |
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia |
https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04365257 |
Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) |
https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04363593 |
Serology COVID-19 From the Cornwall Hospital Union |
https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04518969 |
Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19 |
https://ClinicalTrials.gov/show/NCT04518969 |
| NCT04392778 |
Clinical Use of Stem Cells for the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04372017 |
Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04368299 |
Telemedicine for Follow-up of Systemic Lupus Erythematosus |
https://ClinicalTrials.gov/show/NCT04368299 |
| NCT04365699 |
Cardiovascular Effects of COVID-19 |
https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04364802 |
COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients |
https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04428268 |
Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04428268 |
| NCT04373824 |
Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study |
https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04368676 |
Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness |
https://ClinicalTrials.gov/show/NCT04368676 |
| NCT04366856 |
PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study) |
https://ClinicalTrials.gov/show/NCT04366856 |
| NCT04365985 |
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04365738 |
Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04370782 |
Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting |
https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04400032 |
Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard |
https://ClinicalTrials.gov/show/NCT04400032 |
| NCT04389710 |
Convalescent Plasma for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04379453 |
Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses |
https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04374565 |
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia |
https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04372693 |
Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement |
https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04369794 |
COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement |
https://ClinicalTrials.gov/show/NCT04369794 |
| NCT04369456 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients |
https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04369365 |
A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic |
https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369066 |
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur |
https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04368728 |
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals |
https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04367831 |
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04367545 |
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04367077 |
MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) |
https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04366232 |
Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV) |
https://ClinicalTrials.gov/show/NCT04366232 |
| NCT04366180 |
Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04370262 |
Multi-site Adaptive Trials for COVID-19 |
https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04406181 |
Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04379154 |
Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04376476 |
Host-pathogen Interactions During SARS-CoV-2 Infection |
https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04371510 |
Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients |
https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04371419 |
COVID-19 Health Messaging to Underserved Communities |
https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04371393 |
MSCs in COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04371029 |
Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS |
https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04370886 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 |
https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04369599 |
Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19 |
https://ClinicalTrials.gov/show/NCT04369599 |
| NCT04369469 |
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04369469 |
| NCT04410354 |
Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19 |
https://ClinicalTrials.gov/show/NCT04410354 |
| NCT04392219 |
COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04392219 |
| NCT04387955 |
Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID) |
https://ClinicalTrials.gov/show/NCT04387955 |
| NCT04385810 |
Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 |
https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04384588 |
COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) |
https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04380532 |
Tableted COVID-19 Therapeutic Vaccine |
https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04378712 |
Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04375202 |
Colchicine in COVID-19: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04374487 |
Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications |
https://ClinicalTrials.gov/show/NCT04374487 |
| NCT04372186 |
A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04372004 |
Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) |
https://ClinicalTrials.gov/show/NCT04372004 |
| NCT04371965 |
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04371965 |
| NCT04371367 |
Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) |
https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04370938 |
Provider Burnout During COVID-19 |
https://ClinicalTrials.gov/show/NCT04370938 |
| NCT04370288 |
Clinical Application of Methylene Blue for Treatment of Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04370236 |
INB03 for the Treatment of Pulmonary Complications From COVID-19 |
https://ClinicalTrials.gov/show/NCT04370236 |
| NCT04369820 |
C5a Receptor Expression - COVID-19 (C5-COV) |
https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04408066 |
COVID-19: A POC Test Under Research & Evaluation |
https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04379531 |
LDCT in COVID-19 Pneumonia: a Prospective Moscow Study |
https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04377568 |
Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children |
https://ClinicalTrials.gov/show/NCT04377568 |
| NCT04374942 |
Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? |
https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04374032 |
Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04373460 |
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications |
https://ClinicalTrials.gov/show/NCT04373460 |
| NCT04373382 |
Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04373382 |
| NCT04373161 |
Home Pulse Oximeter Use in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04373135 |
Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 |
https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04372628 |
Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 |
https://ClinicalTrials.gov/show/NCT04372628 |
| NCT04372680 |
WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound |
https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04372602 |
Duvelisib to Combat COVID-19 |
https://ClinicalTrials.gov/show/NCT04372602 |
| NCT04371978 |
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19 |
https://ClinicalTrials.gov/show/NCT04371978 |
| NCT04383002 |
High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients) |
https://ClinicalTrials.gov/show/NCT04383002 |
| NCT04379271 |
A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04379271 |
| NCT04378738 |
Social Media and Covid19 Pandemic |
https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04377789 |
Effect of Quercetin on Prophylaxis and Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04376788 |
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04376788 |
| NCT04375124 |
Treatment of Angiotensin Peptide (1-7) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04374786 |
Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04374461 |
A Study of N-acetylcysteine in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04374019 |
Novel Agents for Treatment of High-risk COVID-19 Positive Patients |
https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04373733 |
Early Intervention in COVID-19: Favipiravir Verses Standard Care |
https://ClinicalTrials.gov/show/NCT04373733 |
| NCT04373707 |
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 |
https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04373291 |
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04373291 |
| NCT04374591 |
The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374539 |
Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04374526 |
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. |
https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04394455 |
Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms |
https://ClinicalTrials.gov/show/NCT04394455 |
| NCT04392531 |
Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 |
https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04376814 |
Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 |
https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04376593 |
PET/CT Imaging in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04375098 |
Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04581031 |
COntinuous Signs Monitoring In Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04581031 |
| NCT04391712 |
Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease |
https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04385043 |
Hyperimmune Plasma in Patients With COVID-19 Severe Infection |
https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04380935 |
Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04380935 |
| NCT04380818 |
Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 |
https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04379375 |
Nudges to Improve Health Behaviors That Limit COVID-19 Spread |
https://ClinicalTrials.gov/show/NCT04379375 |
| NCT04379336 |
BCG Vaccination for Healthcare Workers in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04378803 |
Mindfulness Training for Seniors |
https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04377672 |
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377659 |
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04377620 |
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) |
https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04377477 |
COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) |
https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04377165 |
Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities |
https://ClinicalTrials.gov/show/NCT04377165 |
| NCT04376684 |
Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease |
https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04375397 |
Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury |
https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04376840 |
Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19 |
https://ClinicalTrials.gov/show/NCT04376840 |
| NCT04388527 |
COVID-19 Convalescent Plasma for Mechanically Ventilated Population |
https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04392713 |
Efficacy of Ivermectin in COVID-19 |
https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04389372 |
Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse |
https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04385108 |
Predictive Immune Biomarkers for COVID-19 Pathogenesis |
https://ClinicalTrials.gov/show/NCT04385108 |
| NCT04383613 |
Prone Positioning for Patients on General Medical Wards With COVID19 |
https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04382560 |
Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04382560 |
| NCT04381884 |
Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04379076 |
InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort |
https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04379037 |
Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04379037 |
| NCT04378920 |
A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes |
https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04377711 |
A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04377711 |
| NCT04379661 |
SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 |
https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04377100 |
Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses |
https://ClinicalTrials.gov/show/NCT04377100 |
| NCT04433910 |
A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04433910 |
| NCT04385901 |
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth |
https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04384549 |
Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers |
https://ClinicalTrials.gov/show/NCT04384549 |
| NCT04383535 |
Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia |
https://ClinicalTrials.gov/show/NCT04383535 |
| NCT04382768 |
Inhaled Ibuprofen to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382092 |
Co-infection Management in COVID-19 Critically Ill |
https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04380701 |
A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380519 |
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04380376 |
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia |
https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04379518 |
Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients |
https://ClinicalTrials.gov/show/NCT04379518 |
| NCT04381858 |
Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04381858 |
| NCT04521309 |
SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04521309 |
| NCT04390477 |
Study to Evaluate the Effect of a Probiotic in COVID-19 |
https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04390139 |
Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04390022 |
Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial |
https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04384731 |
Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04384731 |
| NCT04384497 |
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study |
https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04382755 |
Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04382755 |
| NCT04382586 |
Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants |
https://ClinicalTrials.gov/show/NCT04382586 |
| NCT04382066 |
Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04382040 |
A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04381962 |
A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2) |
https://ClinicalTrials.gov/show/NCT04381962 |
| NCT04381377 |
Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 |
https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04381364 |
Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) |
https://ClinicalTrials.gov/show/NCT04381364 |
| NCT04381000 |
Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. |
https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04380961 |
A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 |
https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04380909 |
ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation |
https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04382846 |
Novel Regimens in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04382846 |
| NCT04381936 |
Randomised Evaluation of COVID-19 Therapy |
https://ClinicalTrials.gov/show/NCT04381936 |
| NCT04380688 |
Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. |
https://ClinicalTrials.gov/show/NCT04380688 |
| NCT04400929 |
Using GM-CSF as a Host Directed Therapeutic Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04400929 |
| NCT04394416 |
Trial of Imatinib for Hospitalized Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04394377 |
Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial |
https://ClinicalTrials.gov/show/NCT04394377 |
| NCT04390464 |
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) |
https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04389294 |
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists |
https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04386694 |
Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04384965 |
Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04384458 |
Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis |
https://ClinicalTrials.gov/show/NCT04384458 |
| NCT04382729 |
Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04382547 |
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04382131 |
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19) |
https://ClinicalTrials.gov/show/NCT04382131 |
| NCT04381988 |
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy |
https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04405986 |
Exploring Brain Damages After COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04382651 |
Study of Efficacy and Safety of MAS825 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04382651 |
| NCT04382924 |
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04382924 |
| NCT04382053 |
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04389333 |
Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04387760 |
Favipiravir vs Hydroxychloroquine in COVID -19 |
https://ClinicalTrials.gov/show/NCT04387760 |
| NCT04385199 |
Convalescent Plasma for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04383574 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) |
https://ClinicalTrials.gov/show/NCT04383574 |
| NCT04384445 |
Zofin (Organicell Flow) for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384445 |
| NCT04385017 |
Role of Inflammasomes in COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04392973 |
FAvipiravir and HydroxyChloroquine Combination Therapy |
https://ClinicalTrials.gov/show/NCT04392973 |
| NCT04391140 |
Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS |
https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04385836 |
Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |
https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04446104 |
A Preventive Treatment for Migrant Workers at High-risk of COVID-19 |
https://ClinicalTrials.gov/show/NCT04446104 |
| NCT04442191 |
Convalescent Plasma as a Possible Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04442191 |
| NCT04393636 |
Digital Cardiac Counseling Trial: DCC Trial |
https://ClinicalTrials.gov/show/NCT04393636 |
| NCT04393077 |
Emotional Freedom Technique (EFT) Effect on Nurses |
https://ClinicalTrials.gov/show/NCT04393077 |
| NCT04388514 |
Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04387409 |
Study to Assess VPM1002 in Reducing Healthcare Professionals’ Absenteeism in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04387409 |
| NCT04386850 |
Oral 25-hydroxyvitamin D3 and COVID-19 |
https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04386616 |
A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04386291 |
Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04384900 |
Accelerated Prone Position Ventilation of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04384900 |
| NCT04522128 |
Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life? |
https://ClinicalTrials.gov/show/NCT04522128 |
| NCT04412330 |
Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 |
https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04402944 |
Pulmozyme to Improve COVID-19 ARDS Outcomes |
https://ClinicalTrials.gov/show/NCT04402944 |
| NCT04391127 |
Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390191 |
Early CPAP in COVID-19 Confirmed or Suspected Patients |
https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04389944 |
Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389385 |
COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) |
https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04388410 |
Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04388410 |
| NCT04387292 |
Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic |
https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04387253 |
Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID |
https://ClinicalTrials.gov/show/NCT04387253 |
| NCT04386668 |
Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic |
https://ClinicalTrials.gov/show/NCT04386668 |
| NCT04402957 |
LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04402957 |
| NCT04400838 |
Investigating a Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04400838 |
| NCT04479202 |
The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04479202 |
| NCT04416919 |
Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment |
https://ClinicalTrials.gov/show/NCT04416919 |
| NCT04405076 |
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older |
https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04394403 |
Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress |
https://ClinicalTrials.gov/show/NCT04394403 |
| NCT04394169 |
Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04394169 |
| NCT04392414 |
Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04391829 |
Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males |
https://ClinicalTrials.gov/show/NCT04391829 |
| NCT04390412 |
Low Dose Radiotherapy in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04389840 |
Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04388683 |
Inhaled Nitric Oxide for Preventing Progression in COVID-19 |
https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04388826 |
COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 |
https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04420390 |
Low Dose Radiotherapy for COVID-19 Pneumonitis |
https://ClinicalTrials.gov/show/NCT04420390 |
| NCT04390594 |
Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal |
https://ClinicalTrials.gov/show/NCT04390594 |
| NCT04390516 |
Respiratory Decompensation and Model for the Triage of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04390503 |
Convalescent Plasma for COVID-19 Close Contacts |
https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04389450 |
Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04389450 |
| NCT04397718 |
Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04397718 |
| NCT04474483 |
Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04474483 |
| NCT04408040 |
Use of Convalescent Plasma for COVID-19 |
https://ClinicalTrials.gov/show/NCT04408040 |
| NCT04400799 |
Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04400799 |
| NCT04395144 |
COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss |
https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04394208 |
Silymarin in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04394208 |
| NCT04394182 |
Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 |
https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04393948 |
Lung Irradiation for COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04393948 |
| NCT04393415 |
Using PRP and Cord Blood in Treatment of Covid -19 |
https://ClinicalTrials.gov/show/NCT04393415 |
| NCT04392323 |
Incidence of COVID-19 Test Conversion in Post-surgical Patients |
https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392232 |
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection |
https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392141 |
Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04391179 |
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04407208 |
Convalescent Plasma Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04396106 |
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04396106 |
| NCT04395105 |
Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04393727 |
Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04393246 |
mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms |
https://ClinicalTrials.gov/show/NCT04393246 |
| NCT04398004 |
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early |
https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04394793 |
Low Dose Radiation Therapy for Covid-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04394793 |
| NCT04394442 |
Hydroxychloroquine in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04407130 |
Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. |
https://ClinicalTrials.gov/show/NCT04407130 |
| NCT04395911 |
Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections |
https://ClinicalTrials.gov/show/NCT04395911 |
| NCT04421625 |
Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04421625 |
| NCT04418206 |
Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04418206 |
| NCT04405999 |
Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease |
https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04403269 |
NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE |
https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402918 |
Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy |
https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04399317 |
Flow Controlled Ventilation in ARDS Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04399317 |
| NCT04397796 |
Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04397796 |
| NCT04395807 |
Helmet CPAP Versus HFNC in COVID-19 |
https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04395768 |
International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 |
https://ClinicalTrials.gov/show/NCT04395768 |
| NCT04394117 |
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease |
https://ClinicalTrials.gov/show/NCT04394117 |
| NCT04394013 |
A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period |
https://ClinicalTrials.gov/show/NCT04394013 |
| NCT04393818 |
Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 |
https://ClinicalTrials.gov/show/NCT04393818 |
| NCT04393792 |
SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 |
https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393038 |
ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04416360 |
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04402203 |
Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh |
https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04399967 |
COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via “Quit to Win” Contest 2020 |
https://ClinicalTrials.gov/show/NCT04399967 |
| NCT04399746 |
Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 |
https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04399356 |
Niclosamide for Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04399356 |
| NCT04399252 |
Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19 |
https://ClinicalTrials.gov/show/NCT04399252 |
| NCT04399005 |
The Efficacy Comparing Daily and After-each-case Room Disinfection. |
https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04397692 |
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial) |
https://ClinicalTrials.gov/show/NCT04397692 |
| NCT04397562 |
A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04407286 |
Vitamin D Testing and Treatment for COVID 19 |
https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04397757 |
COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. |
https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04414631 |
Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04414631 |
| NCT04397510 |
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury |
https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04441684 |
Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19) |
https://ClinicalTrials.gov/show/NCT04441684 |
| NCT04403477 |
Convalescent Plasma Therapy in Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04402970 |
Dornase Alfa for ARDS in Patients With SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04398277 |
A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04397666 |
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04397523 |
Efficacy and Safety of COVID-19 Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04401293 |
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04552951 |
Effect of Vitamin D on Morbidity and Mortality of the COVID-19 |
https://ClinicalTrials.gov/show/NCT04552951 |
| NCT04413006 |
Self-compassion for Chronic Pain Virtual Group Treatment Program |
https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04412538 |
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04410549 |
Pulmonary Optical Coherence Tomography in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04401423 |
TXA127 for the Treatment of Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04401423 |
| NCT04401410 |
Anti-SARS Cov-2 T Cell Infusions for COVID 19 |
https://ClinicalTrials.gov/show/NCT04401410 |
| NCT04401202 |
Nigella Sativa in COVID-19 |
https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04401150 |
Lessening Organ Dysfunction With VITamin C - COVID-19 |
https://ClinicalTrials.gov/show/NCT04401150 |
| NCT04400305 |
“Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” |
https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04400279 |
The COVID-19 Pandemic and Exercise Study |
https://ClinicalTrials.gov/show/NCT04400279 |
| NCT04400058 |
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression |
https://ClinicalTrials.gov/show/NCT04400058 |
| NCT04399980 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04399889 |
hCT-MSCs for COVID19 ARDS |
https://ClinicalTrials.gov/show/NCT04399889 |
| NCT04399681 |
The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 |
https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04399109 |
Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) |
https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04411602 |
Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD |
https://ClinicalTrials.gov/show/NCT04411602 |
| NCT04410016 |
Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study |
https://ClinicalTrials.gov/show/NCT04410016 |
| NCT04407390 |
Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly |
https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04404426 |
CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04404426 |
| NCT04402983 |
The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402879 |
CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals |
https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04402866 |
TD-0903 for ALI Associated With COVID-19 |
https://ClinicalTrials.gov/show/NCT04402866 |
| NCT04402840 |
Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04402060 |
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04402060 |
| NCT04401046 |
COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder |
https://ClinicalTrials.gov/show/NCT04401046 |
| NCT04400890 |
Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19 |
https://ClinicalTrials.gov/show/NCT04400890 |
| NCT04401579 |
Adaptive COVID-19 Treatment Trial 2 (ACTT-2) |
https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04408183 |
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel |
https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04404361 |
PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer |
https://ClinicalTrials.gov/show/NCT04404361 |
| NCT04411433 |
Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04406493 |
Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique |
https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04403555 |
Ivermectin and Doxycycine in COVID-19 Treatment |
https://ClinicalTrials.gov/show/NCT04403555 |
| NCT04403100 |
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: “The Hope Coalition - 1” |
https://ClinicalTrials.gov/show/NCT04403100 |
| NCT04405843 |
Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial) |
https://ClinicalTrials.gov/show/NCT04405843 |
| NCT04429711 |
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04429711 |
| NCT04412356 |
Timing of Tracheotomy in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04408456 |
Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04406246 |
Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide |
https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04404218 |
The Açaà Berry COVID-19 Anti-Inflammation Trial |
https://ClinicalTrials.gov/show/NCT04404218 |
| NCT04403685 |
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers |
https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04417335 |
Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination |
https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04410536 |
Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency |
https://ClinicalTrials.gov/show/NCT04410536 |
| NCT04408209 |
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04407182 |
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 |
https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04405908 |
SCB-2019 as COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04405908 |
| NCT04430608 |
Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04430608 |
| NCT04414618 |
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia |
https://ClinicalTrials.gov/show/NCT04414618 |
| NCT04411446 |
Cholecalciferol to Improve the Outcomes of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04411446 |
| NCT04410562 |
Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy |
https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04409496 |
Chat-based Support for Preventing Smoking Relapse |
https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04408157 |
A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04408157 |
| NCT04406389 |
Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial) |
https://ClinicalTrials.gov/show/NCT04406389 |
| NCT04405544 |
Determination of Acute Encephalopathy Predictors in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04405310 |
Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial |
https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04405102 |
COVID-19 Ozanimod Intervention Study |
https://ClinicalTrials.gov/show/NCT04405102 |
| NCT04405570 |
A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 |
https://ClinicalTrials.gov/show/NCT04405570 |
| NCT04405739 |
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID) |
https://ClinicalTrials.gov/show/NCT04405739 |
| NCT04457609 |
Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04457609 |
| NCT04444271 |
Mesenchymal Stem Cell Infusion for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04444271 |
| NCT04425317 |
Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04425317 |
| NCT04416308 |
COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) |
https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04410692 |
Can the Prediction Market Improve Predictions of COVID-19? |
https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04410510 |
P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04410510 |
| NCT04410159 |
Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04410159 |
| NCT04407689 |
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort |
https://ClinicalTrials.gov/show/NCT04407689 |
| NCT04412486 |
COVID-19 Convalescent Plasma (CCP) Transfusion |
https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04410328 |
Aggrenox To Treat Acute Covid-19 |
https://ClinicalTrials.gov/show/NCT04410328 |
| NCT04409834 |
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial |
https://ClinicalTrials.gov/show/NCT04409834 |
| NCT04409522 |
Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients |
https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04409509 |
Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04409509 |
| NCT04409262 |
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04409262 |
| NCT04408131 |
Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study |
https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04417257 |
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults |
https://ClinicalTrials.gov/show/NCT04417257 |
| NCT04409327 |
Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes |
https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04433546 |
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). |
https://ClinicalTrials.gov/show/NCT04433546 |
| NCT04409743 |
Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04427098 |
Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04427098 |
| NCT04424901 |
Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04424901 |
| NCT04418947 |
Project Resurgence Communication Trial |
https://ClinicalTrials.gov/show/NCT04418947 |
| NCT04412343 |
The Seniors COvid-19 Pandemic and Exercise Study |
https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04412057 |
Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury |
https://ClinicalTrials.gov/show/NCT04412057 |
| NCT04412018 |
An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 |
https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04411667 |
Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04411628 |
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 |
https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04410458 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） |
https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04420182 |
COVID-19 Virtual Care at Home |
https://ClinicalTrials.gov/show/NCT04420182 |
| NCT04411680 |
Study of Sargramostim in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04411680 |
| NCT04416139 |
Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 |
https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04412239 |
To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04414371 |
Tools for Wellbeing COVID-19 National Study of Undergraduate Students |
https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04424953 |
To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn |
https://ClinicalTrials.gov/show/NCT04424953 |
| NCT04417270 |
Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge |
https://ClinicalTrials.gov/show/NCT04417270 |
| NCT04415086 |
Treatment of Patients With COVID-19 With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04415086 |
| NCT04414267 |
Bacillus Calmette-guérin Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04414124 |
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04412785 |
Cyclosporine in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04412785 |
| NCT04412772 |
Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS |
https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04412668 |
Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04412668 |
| NCT04412291 |
A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study |
https://ClinicalTrials.gov/show/NCT04412291 |
| NCT04425720 |
Use of Remote Monitoring for COVID-19 Patient |
https://ClinicalTrials.gov/show/NCT04425720 |
| NCT04420247 |
Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 |
https://ClinicalTrials.gov/show/NCT04420247 |
| NCT04415060 |
SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival |
https://ClinicalTrials.gov/show/NCT04415060 |
| NCT04413968 |
COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants |
https://ClinicalTrials.gov/show/NCT04413968 |
| NCT04415151 |
Tofacitinib for Treatment of Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04415151 |
| NCT04453852 |
Monovalent Recombinant COVID19 Vaccine |
https://ClinicalTrials.gov/show/NCT04453852 |
| NCT04439045 |
Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity |
https://ClinicalTrials.gov/show/NCT04439045 |
| NCT04426305 |
Community Health Workers Against COVID19 |
https://ClinicalTrials.gov/show/NCT04426305 |
| NCT04425616 |
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer |
https://ClinicalTrials.gov/show/NCT04425616 |
| NCT04422509 |
Lanadelumab for Treatment of COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04422509 |
| NCT04421404 |
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04421404 |
| NCT04420273 |
Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access |
https://ClinicalTrials.gov/show/NCT04420273 |
| NCT04419623 |
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer |
https://ClinicalTrials.gov/show/NCT04419623 |
| NCT04419025 |
Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease |
https://ClinicalTrials.gov/show/NCT04419025 |
| NCT04418518 |
A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness |
https://ClinicalTrials.gov/show/NCT04418518 |
| NCT04418505 |
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms |
https://ClinicalTrials.gov/show/NCT04418505 |
| NCT04416399 |
STerOids in COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04416399 |
| NCT04416334 |
PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS |
https://ClinicalTrials.gov/show/NCT04416334 |
| NCT04435808 |
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 |
https://ClinicalTrials.gov/show/NCT04435808 |
| NCT04424212 |
ICBT for Mental Health Problems Related to the Coronavirus Pandemic |
https://ClinicalTrials.gov/show/NCT04424212 |
| NCT04421391 |
QuadraMune(TM) for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04421391 |
| NCT04420741 |
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04420741 |
| NCT04420676 |
Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04420676 |
| NCT04541979 |
Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04541979 |
| NCT04513990 |
Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04513990 |
| NCT04427566 |
Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise |
https://ClinicalTrials.gov/show/NCT04427566 |
| NCT04425031 |
Handling Oxygenation Targets in COVID-19 |
https://ClinicalTrials.gov/show/NCT04425031 |
| NCT04424797 |
Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol |
https://ClinicalTrials.gov/show/NCT04424797 |
| NCT04422613 |
Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04422613 |
| NCT04421664 |
Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) |
https://ClinicalTrials.gov/show/NCT04421664 |
| NCT04420806 |
Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT04420806 |
| NCT04420338 |
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study |
https://ClinicalTrials.gov/show/NCT04420338 |
| NCT04420299 |
Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19 |
https://ClinicalTrials.gov/show/NCT04420299 |
| NCT04421508 |
A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04421508 |
| NCT04421027 |
A Study of Baricitinib (LY3009104) in Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04421027 |
| NCT04441918 |
Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects |
https://ClinicalTrials.gov/show/NCT04441918 |
| NCT04423289 |
Telematic Monitoring Through a Mobile Application of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04423289 |
| NCT04422561 |
Prophylactic Ivermectin in COVID-19 Contacts |
https://ClinicalTrials.gov/show/NCT04422561 |
| NCT04428021 |
Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04428021 |
| NCT04425915 |
Efficacy of Convalescent Plasma Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425915 |
| NCT04424082 |
External Dead Space in Ventilated COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04424082 |
| NCT04422353 |
Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson’s Disease |
https://ClinicalTrials.gov/show/NCT04422353 |
| NCT04425707 |
Ivermectin In Treatment of COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04425707 |
| NCT04475601 |
Enzalutamide Treatment in COVID-19 |
https://ClinicalTrials.gov/show/NCT04475601 |
| NCT04442087 |
Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP |
https://ClinicalTrials.gov/show/NCT04442087 |
| NCT04426695 |
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04426695 |
| NCT04426292 |
SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04426292 |
| NCT04425538 |
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19). |
https://ClinicalTrials.gov/show/NCT04425538 |
| NCT04425005 |
Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric |
https://ClinicalTrials.gov/show/NCT04425005 |
| NCT04423991 |
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning |
https://ClinicalTrials.gov/show/NCT04423991 |
| NCT04425629 |
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425629 |
| NCT04431453 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04431453 |
| NCT04497389 |
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04497389 |
| NCT04458948 |
Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04458948 |
| NCT04445246 |
Inhaled Iloprost for Suspected COVID-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04445246 |
| NCT04434131 |
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04434131 |
| NCT04429854 |
Donated Antibodies Working Against nCoV |
https://ClinicalTrials.gov/show/NCT04429854 |
| NCT04429529 |
Safety of TY027, a Treatment for COVID-19, in Humans |
https://ClinicalTrials.gov/show/NCT04429529 |
| NCT04428099 |
Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression |
https://ClinicalTrials.gov/show/NCT04428099 |
| NCT04426318 |
COVID-19 and the Healthy Minds Program for Educators |
https://ClinicalTrials.gov/show/NCT04426318 |
| NCT04425252 |
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04425252 |
| NCT04426006 |
Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04426006 |
| NCT04427501 |
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness |
https://ClinicalTrials.gov/show/NCT04427501 |
| NCT04584541 |
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism |
https://ClinicalTrials.gov/show/NCT04584541 |
| NCT04429724 |
Health Professional Exposure Assessment to Covid-19 |
https://ClinicalTrials.gov/show/NCT04429724 |
| NCT04470258 |
Elmo Respiratory Support Project - COVID-19 |
https://ClinicalTrials.gov/show/NCT04470258 |
| NCT04433078 |
RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM |
https://ClinicalTrials.gov/show/NCT04433078 |
| NCT04431466 |
A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19 |
https://ClinicalTrials.gov/show/NCT04431466 |
| NCT04429867 |
Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease |
https://ClinicalTrials.gov/show/NCT04429867 |
| NCT04429594 |
Study of the Incidence of SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04429594 |
| NCT04427137 |
Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04427137 |
| NCT04623255 |
Randomised Study of Plasma Exchange in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04623255 |
| NCT04555005 |
Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19 |
https://ClinicalTrials.gov/show/NCT04555005 |
| NCT04435717 |
Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01) |
https://ClinicalTrials.gov/show/NCT04435717 |
| NCT04432051 |
The Use of Lung Ultrasonography in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04432051 |
| NCT04441424 |
Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04441424 |
| NCT04433949 |
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04433949 |
| NCT04432324 |
Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04432324 |
| NCT04432272 |
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) |
https://ClinicalTrials.gov/show/NCT04432272 |
| NCT04431180 |
Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial# |
https://ClinicalTrials.gov/show/NCT04431180 |
| NCT04647604 |
Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids - |
https://ClinicalTrials.gov/show/NCT04647604 |
| NCT04431856 |
CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment |
https://ClinicalTrials.gov/show/NCT04431856 |
| NCT04432298 |
Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04432298 |
| NCT04445272 |
Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04445272 |
| NCT04434248 |
An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04434248 |
| NCT04435353 |
Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19 |
https://ClinicalTrials.gov/show/NCT04435353 |
| NCT04444674 |
COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection |
https://ClinicalTrials.gov/show/NCT04444674 |
| NCT04436276 |
A Study of Ad26.COV2.S in Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04436276 |
| NCT04435522 |
Maraviroc in Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04435522 |
| NCT04432987 |
Dornase Alpha for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04432987 |
| NCT04432805 |
Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04432805 |
| NCT04499677 |
FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals |
https://ClinicalTrials.gov/show/NCT04499677 |
| NCT04449718 |
Vitamin D Supplementation in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04449718 |
| NCT04447781 |
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 |
https://ClinicalTrials.gov/show/NCT04447781 |
| NCT04438694 |
Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04438694 |
| NCT04437875 |
An Open Study of the Safety, Tolerability and Immunogenicity of “Gam-COVID-Vac Lyo” Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04437875 |
| NCT04436471 |
An Open Study of the Safety, Tolerability and Immunogenicity of the Drug “Gam-COVID-Vac” Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04436471 |
| NCT04435795 |
Inhaled Ciclesonide for Outpatients With COVID19 |
https://ClinicalTrials.gov/show/NCT04435795 |
| NCT04435184 |
Crizanlizumab for Treating COVID-19 Vasculopathy |
https://ClinicalTrials.gov/show/NCT04435184 |
| NCT04435379 |
Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04435379 |
| NCT04497948 |
Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04497948 |
| NCT04445194 |
Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine |
https://ClinicalTrials.gov/show/NCT04445194 |
| NCT04442958 |
Effectiveness of Convalescent Immune Plasma Therapy |
https://ClinicalTrials.gov/show/NCT04442958 |
| NCT04442230 |
NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04442230 |
| NCT04439071 |
A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04439071 |
| NCT04439006 |
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04439006 |
| NCT04438070 |
COVID Screening Strategies in Homeless Shelters |
https://ClinicalTrials.gov/show/NCT04438070 |
| NCT04438057 |
Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04438057 |
| NCT04437823 |
Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04437823 |
| NCT04437719 |
Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04437719 |
| NCT04440007 |
Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04440007 |
| NCT04450004 |
Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. |
https://ClinicalTrials.gov/show/NCT04450004 |
| NCT04449276 |
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04449276 |
| NCT04444596 |
Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04444596 |
| NCT04443881 |
Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS) |
https://ClinicalTrials.gov/show/NCT04443881 |
| NCT04443673 |
Glycine Supplement for Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04443673 |
| NCT04441632 |
Effect of Positive Attitudes on Behavior and Wellness |
https://ClinicalTrials.gov/show/NCT04441632 |
| NCT04441385 |
Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). |
https://ClinicalTrials.gov/show/NCT04441385 |
| NCT04438980 |
Glucocorticoids in COVID-19 (CORTIVID) |
https://ClinicalTrials.gov/show/NCT04438980 |
| NCT04445454 |
Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04445454 |
| NCT04445389 |
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04445389 |
| NCT04445311 |
Ivermectin in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04445311 |
| NCT04442178 |
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) |
https://ClinicalTrials.gov/show/NCT04442178 |
| NCT04442152 |
Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants |
https://ClinicalTrials.gov/show/NCT04442152 |
| NCT04442048 |
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure |
https://ClinicalTrials.gov/show/NCT04442048 |
| NCT04441996 |
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity |
https://ClinicalTrials.gov/show/NCT04441996 |
| NCT04466683 |
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia |
https://ClinicalTrials.gov/show/NCT04466683 |
| NCT04447235 |
Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04447235 |
| NCT04445467 |
An Adaptive Clinical Trial of Antivirals for COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04445467 |
| NCT04445428 |
OPV as Potential Protection Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04445428 |
| NCT04445376 |
Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery. |
https://ClinicalTrials.gov/show/NCT04445376 |
| NCT04445324 |
Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19 |
https://ClinicalTrials.gov/show/NCT04445324 |
| NCT04445285 |
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04445285 |
| NCT04445220 |
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy |
https://ClinicalTrials.gov/show/NCT04445220 |
| NCT04444700 |
A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04444700 |
| NCT04445597 |
ANalyzing Olfactory Dysfunction Mechanisms In COVID-19 |
https://ClinicalTrials.gov/show/NCT04445597 |
| NCT04473274 |
GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study |
https://ClinicalTrials.gov/show/NCT04473274 |
| NCT04453384 |
Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia |
https://ClinicalTrials.gov/show/NCT04453384 |
| NCT04446429 |
Anti-Androgen Treatment for COVID-19 |
https://ClinicalTrials.gov/show/NCT04446429 |
| NCT04456361 |
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04456361 |
| NCT04449380 |
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04449380 |
| NCT04448769 |
Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) |
https://ClinicalTrials.gov/show/NCT04448769 |
| NCT04447469 |
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04447469 |
| NCT04447404 |
DUR-928 in Subjects With SARS-CoV-2 With Acute Liver or Kidney Injury |
https://ClinicalTrials.gov/show/NCT04447404 |
| NCT04446377 |
A Study of LAM-002A for the Prevention of Progression of COVID-19 |
https://ClinicalTrials.gov/show/NCT04446377 |
| NCT04445935 |
Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial |
https://ClinicalTrials.gov/show/NCT04445935 |
| NCT04447534 |
Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04447534 |
| NCT04448119 |
Control of COVID-19 Outbreaks in Long Term Care |
https://ClinicalTrials.gov/show/NCT04448119 |
| NCT04458363 |
Convalescent Plasma in Pediatric COVID-19 |
https://ClinicalTrials.gov/show/NCT04458363 |
| NCT04452773 |
Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04452773 |
| NCT04448756 |
M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia |
https://ClinicalTrials.gov/show/NCT04448756 |
| NCT04455815 |
A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home |
https://ClinicalTrials.gov/show/NCT04455815 |
| NCT04464486 |
Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic |
https://ClinicalTrials.gov/show/NCT04464486 |
| NCT04463264 |
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04463264 |
| NCT04455360 |
Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial |
https://ClinicalTrials.gov/show/NCT04455360 |
| NCT04454606 |
The New Silicone N99 Half-Piece Respirator |
https://ClinicalTrials.gov/show/NCT04454606 |
| NCT04453657 |
Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19 |
https://ClinicalTrials.gov/show/NCT04453657 |
| NCT04452565 |
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04452565 |
| NCT04452318 |
Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay |
https://ClinicalTrials.gov/show/NCT04452318 |
| NCT04451174 |
Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04451174 |
| NCT04449588 |
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS |
https://ClinicalTrials.gov/show/NCT04449588 |
| NCT04525742 |
COVID-19 Pandemic and Parents of Disabled Children |
https://ClinicalTrials.gov/show/NCT04525742 |
| NCT04469621 |
A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04469621 |
| NCT04464408 |
Favipiravir Therapy in Adults With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04464408 |
| NCT04479163 |
Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2 |
https://ClinicalTrials.gov/show/NCT04479163 |
| NCT04459455 |
Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04459455 |
| NCT04458298 |
A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04458298 |
| NCT04453475 |
Feasibility and Benefits of Digital Services During the COVID19 Pandemic |
https://ClinicalTrials.gov/show/NCT04453475 |
| NCT04452435 |
Safety and Efficacy of C21 in Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04452435 |
| NCT04451889 |
Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04451889 |
| NCT04457388 |
Tele-Yoga Therapy for Chronic Pain |
https://ClinicalTrials.gov/show/NCT04457388 |
| NCT04457349 |
Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19 |
https://ClinicalTrials.gov/show/NCT04457349 |
| NCT04456452 |
Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation |
https://ClinicalTrials.gov/show/NCT04456452 |
| NCT04456413 |
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04456413 |
| NCT04456153 |
Atovaquone for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04456153 |
| NCT04456062 |
Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04456062 |
| NCT04455308 |
COVID-19 and Chilblains |
https://ClinicalTrials.gov/show/NCT04455308 |
| NCT04454398 |
Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04454398 |
| NCT04453514 |
Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic |
https://ClinicalTrials.gov/show/NCT04453514 |
| NCT04456595 |
Clinical Trial of Efficacy and Safety of Sinovac’s Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals |
https://ClinicalTrials.gov/show/NCT04456595 |
| NCT04482673 |
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04482673 |
| NCT04461925 |
Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs |
https://ClinicalTrials.gov/show/NCT04461925 |
| NCT04460027 |
W-SUDs for COVID-19 |
https://ClinicalTrials.gov/show/NCT04460027 |
| NCT04458519 |
Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection |
https://ClinicalTrials.gov/show/NCT04458519 |
| NCT04458246 |
Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04458246 |
| NCT04465604 |
Hypertonic Saline for COVID-19 Symptoms |
https://ClinicalTrials.gov/show/NCT04465604 |
| NCT04463849 |
Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients |
https://ClinicalTrials.gov/show/NCT04463849 |
| NCT04461379 |
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04461379 |
| NCT04460703 |
COVID-19 Vaccine Messaging, Part 1 |
https://ClinicalTrials.gov/show/NCT04460703 |
| NCT04460651 |
PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial |
https://ClinicalTrials.gov/show/NCT04460651 |
| NCT04460534 |
Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab) |
https://ClinicalTrials.gov/show/NCT04460534 |
| NCT04457726 |
Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04457726 |
| NCT04505761 |
The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 |
https://ClinicalTrials.gov/show/NCT04505761 |
| NCT04470869 |
Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement. |
https://ClinicalTrials.gov/show/NCT04470869 |
| NCT04467918 |
CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms |
https://ClinicalTrials.gov/show/NCT04467918 |
| NCT04466540 |
Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04466540 |
| NCT04460183 |
A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04460183 |
| NCT04459962 |
Covid-19 Breath Test |
https://ClinicalTrials.gov/show/NCT04459962 |
| NCT04459676 |
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04459676 |
| NCT04459325 |
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04459325 |
| NCT04459286 |
The Nitazoxanide Plus Atazanavir for COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04459286 |
| NCT04459247 |
Short Term, High Dose Vitamin D Supplementation for COVID-19 |
https://ClinicalTrials.gov/show/NCT04459247 |
| NCT04463420 |
Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04463420 |
| NCT04461340 |
Efficacy and Safety of Sirolimus in COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04461340 |
| NCT04460443 |
Sofosbuvir in Treatment of COVID 19 |
https://ClinicalTrials.gov/show/NCT04460443 |
| NCT04468139 |
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19 |
https://ClinicalTrials.gov/show/NCT04468139 |
| NCT04459520 |
Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance |
https://ClinicalTrials.gov/show/NCT04459520 |
| NCT04479540 |
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease |
https://ClinicalTrials.gov/show/NCT04479540 |
| NCT04460690 |
Rapid, Onsite COVID-19 Detection |
https://ClinicalTrials.gov/show/NCT04460690 |
| NCT04460677 |
ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04460677 |
| NCT04460014 |
Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT |
https://ClinicalTrials.gov/show/NCT04460014 |
| NCT04466241 |
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial |
https://ClinicalTrials.gov/show/NCT04466241 |
| NCT04472728 |
Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04472728 |
| NCT04468646 |
To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04468646 |
| NCT04464395 |
Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04464395 |
| NCT04463602 |
Desidustat in the Management of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04463602 |
| NCT04463004 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation |
https://ClinicalTrials.gov/show/NCT04463004 |
| NCT04462627 |
Reduction of COVID 19 Transmission to Health Care Professionals |
https://ClinicalTrials.gov/show/NCT04462627 |
| NCT04514627 |
Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04514627 |
| NCT04469179 |
Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19 |
https://ClinicalTrials.gov/show/NCT04469179 |
| NCT04466670 |
Hemostasis in COVID-19: an Adaptive Clinical Trial |
https://ClinicalTrials.gov/show/NCT04466670 |
| NCT04466098 |
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) |
https://ClinicalTrials.gov/show/NCT04466098 |
| NCT04463472 |
Study of COVID-19 DNA Vaccine (AG0301-COVID19) |
https://ClinicalTrials.gov/show/NCT04463472 |
| NCT04466085 |
Clinical Study of Recombinant Novel Coronavirus Vaccine |
https://ClinicalTrials.gov/show/NCT04466085 |
| NCT04473053 |
Rapid Experimental Medicine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04473053 |
| NCT04471636 |
Telemedicine in Outpatient Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04471636 |
| NCT04470999 |
Changes in Cellular Immune Profile During COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04470999 |
| NCT04470544 |
Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04470544 |
| NCT04468009 |
Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04468009 |
| NCT04466800 |
Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19) |
https://ClinicalTrials.gov/show/NCT04466800 |
| NCT04466605 |
Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown |
https://ClinicalTrials.gov/show/NCT04466605 |
| NCT04466280 |
Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04466280 |
| NCT04465695 |
Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19 |
https://ClinicalTrials.gov/show/NCT04465695 |
| NCT04467840 |
Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04467840 |
| NCT04469114 |
Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04469114 |
| NCT04468971 |
REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia |
https://ClinicalTrials.gov/show/NCT04468971 |
| NCT04468893 |
Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04468893 |
| NCT04560231 |
Remdesivir in COVID-19 Lahore General Hospital |
https://ClinicalTrials.gov/show/NCT04560231 |
| NCT04471519 |
Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04471519 |
| NCT04470531 |
Role of Co-trimoxazole in Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04470531 |
| NCT04470427 |
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04470427 |
| NCT04560205 |
Tocilizumab in COVID-19 Lahore General Hospital |
https://ClinicalTrials.gov/show/NCT04560205 |
| NCT04480593 |
The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19. |
https://ClinicalTrials.gov/show/NCT04480593 |
| NCT04470739 |
Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities? |
https://ClinicalTrials.gov/show/NCT04470739 |
| NCT04495933 |
A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04495933 |
| NCT04479358 |
Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04479358 |
| NCT04477993 |
Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04477993 |
| NCT04476667 |
Online Delivery of Psychotherapy, Tailored to Patients’ Suffering From Mental Health Problems Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04476667 |
| NCT04470622 |
Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) |
https://ClinicalTrials.gov/show/NCT04470622 |
| NCT04470609 |
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years |
https://ClinicalTrials.gov/show/NCT04470609 |
| NCT04560257 |
High Flow Nasal Cannula HFNC In Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04560257 |
| NCT04537962 |
Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study |
https://ClinicalTrials.gov/show/NCT04537962 |
| NCT04488081 |
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients |
https://ClinicalTrials.gov/show/NCT04488081 |
| NCT04478539 |
Extracorporeal Blood Purification as a Treatment Modality for COVID-19 |
https://ClinicalTrials.gov/show/NCT04478539 |
| NCT04477083 |
Development and Validation of “Ready-to-Use” Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04477083 |
| NCT04475913 |
Digital vs Analog Impression in Cases of All-on-4 - Prosthesis |
https://ClinicalTrials.gov/show/NCT04475913 |
| NCT04475107 |
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04475107 |
| NCT04473898 |
Telerehabilitation After Coronavirus |
https://ClinicalTrials.gov/show/NCT04473898 |
| NCT04473261 |
Efficacy of Iodine Complex Against COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04473261 |
| NCT04473248 |
Spartan COVID-19 System: Evaluation of Clinical Sample Collection |
https://ClinicalTrials.gov/show/NCT04473248 |
| NCT04473170 |
Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 |
https://ClinicalTrials.gov/show/NCT04473170 |
| NCT04472585 |
Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04472585 |
| NCT04472494 |
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise |
https://ClinicalTrials.gov/show/NCT04472494 |
| NCT04471766 |
Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention |
https://ClinicalTrials.gov/show/NCT04471766 |
| NCT04500067 |
Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment |
https://ClinicalTrials.gov/show/NCT04500067 |
| NCT04481685 |
A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04481685 |
| NCT04478071 |
Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04478071 |
| NCT04478019 |
SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding |
https://ClinicalTrials.gov/show/NCT04478019 |
| NCT04477655 |
Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04477655 |
| NCT04476953 |
COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation |
https://ClinicalTrials.gov/show/NCT04476953 |
| NCT04475575 |
Can the Electronic Nose Smell COVID-19 Antibodies? |
https://ClinicalTrials.gov/show/NCT04475575 |
| NCT04475562 |
Can the Electronic Nose Smell COVID-19? |
https://ClinicalTrials.gov/show/NCT04475562 |
| NCT04475185 |
Safety and Effectiveness Assessment of the MakAir Artificial Ventilator |
https://ClinicalTrials.gov/show/NCT04475185 |
| NCT04474340 |
COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients |
https://ClinicalTrials.gov/show/NCT04474340 |
| NCT04477954 |
Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia |
https://ClinicalTrials.gov/show/NCT04477954 |
| NCT04476992 |
Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement |
https://ClinicalTrials.gov/show/NCT04476992 |
| NCT04476979 |
Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04476979 |
| NCT04476888 |
Convalescent Plasma Treatment in COVID-19 |
https://ClinicalTrials.gov/show/NCT04476888 |
| NCT04475588 |
Efficacy and Safety of Itolizumab in COVID-19 Complications |
https://ClinicalTrials.gov/show/NCT04475588 |
| NCT04475302 |
BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots |
https://ClinicalTrials.gov/show/NCT04475302 |
| NCT04475120 |
Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients |
https://ClinicalTrials.gov/show/NCT04475120 |
| NCT04476745 |
The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People |
https://ClinicalTrials.gov/show/NCT04476745 |
| NCT04483375 |
Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects |
https://ClinicalTrials.gov/show/NCT04483375 |
| NCT04482595 |
BIO 300 Oral Suspension in Discharged COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04482595 |
| NCT04480957 |
Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects |
https://ClinicalTrials.gov/show/NCT04480957 |
| NCT04483271 |
The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm |
https://ClinicalTrials.gov/show/NCT04483271 |
| NCT04480112 |
Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults |
https://ClinicalTrials.gov/show/NCT04480112 |
| NCT04514900 |
Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program |
https://ClinicalTrials.gov/show/NCT04514900 |
| NCT04492891 |
Cyclosporine For The Treatment Of COVID-19(+) |
https://ClinicalTrials.gov/show/NCT04492891 |
| NCT04488484 |
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2. |
https://ClinicalTrials.gov/show/NCT04488484 |
| NCT04485429 |
Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04485429 |
| NCT04480424 |
Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04480424 |
| NCT04480138 |
Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04480138 |
| NCT04570462 |
Mild Hypothermia for COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04570462 |
| NCT04494724 |
Clazakizumab vs. Placebo - COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04494724 |
| NCT04487639 |
Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ? |
https://ClinicalTrials.gov/show/NCT04487639 |
| NCT04485169 |
Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm; |
https://ClinicalTrials.gov/show/NCT04485169 |
| NCT04484207 |
Addressing COVID-19 Mental Health Problems Among US Veterans |
https://ClinicalTrials.gov/show/NCT04484207 |
| NCT04483752 |
Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images |
https://ClinicalTrials.gov/show/NCT04483752 |
| NCT04482621 |
Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial |
https://ClinicalTrials.gov/show/NCT04482621 |
| NCT04482647 |
Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04482647 |
| NCT04482634 |
Tele-rehabilitation Versus Home Exercise Program in COVID-19 |
https://ClinicalTrials.gov/show/NCT04482634 |
| NCT04481633 |
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04481633 |
| NCT04482686 |
Trial of Combination Therapy to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04482686 |
| NCT04488796 |
STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers |
https://ClinicalTrials.gov/show/NCT04488796 |
| NCT04487574 |
A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04487574 |
| NCT04487444 |
Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04487444 |
| NCT04487210 |
A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04487210 |
| NCT04486508 |
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04486508 |
| NCT04484493 |
Corticosteroid Nasal Spray in COVID-19 Anosmia |
https://ClinicalTrials.gov/show/NCT04484493 |
| NCT04483960 |
Australasian COVID-19 Trial (ASCOT): An International Multi-Centre Randomised Clinical Trial to Assess the Clinical, Virological and Immunological Outcomes in Patients Diagnosed With SARS-CoV-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04483960 |
| NCT04483830 |
Suloexide in the Treatment of Early Stages of COVID-19 |
https://ClinicalTrials.gov/show/NCT04483830 |
| NCT04490278 |
CoV-PICS: A Virtual Post-ICU Clinic |
https://ClinicalTrials.gov/show/NCT04490278 |
| NCT04488575 |
Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04488575 |
| NCT04487990 |
CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04487990 |
| NCT04486482 |
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function |
https://ClinicalTrials.gov/show/NCT04486482 |
| NCT04486313 |
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04486313 |
| NCT04487691 |
Nebulized PL for Post-COVID-19 Syndrome |
https://ClinicalTrials.gov/show/NCT04487691 |
| NCT04494386 |
Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS |
https://ClinicalTrials.gov/show/NCT04494386 |
| NCT04487964 |
Complementary Intervention for COVID-19 |
https://ClinicalTrials.gov/show/NCT04487964 |
| NCT04487171 |
Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic |
https://ClinicalTrials.gov/show/NCT04487171 |
| NCT04519437 |
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04519437 |
| NCT04492228 |
Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome |
https://ClinicalTrials.gov/show/NCT04492228 |
| NCT04490473 |
Turkish of the SARS-CoV-2 Anxiety Scale |
https://ClinicalTrials.gov/show/NCT04490473 |
| NCT04489446 |
Sildenafil in COVID-19 |
https://ClinicalTrials.gov/show/NCT04489446 |
| NCT04496245 |
Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85 |
https://ClinicalTrials.gov/show/NCT04496245 |
| NCT04501796 |
A Trial of NT-I7 in COVID-19 (SPESELPIS) |
https://ClinicalTrials.gov/show/NCT04501796 |
| NCT04499313 |
Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04499313 |
| NCT04497623 |
Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons. |
https://ClinicalTrials.gov/show/NCT04497623 |
| NCT04491240 |
Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. |
https://ClinicalTrials.gov/show/NCT04491240 |
| NCT04490824 |
Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals |
https://ClinicalTrials.gov/show/NCT04490824 |
| NCT04518514 |
Telemedical Risk Assessment and Preoperative Evaluation (TAPE) |
https://ClinicalTrials.gov/show/NCT04518514 |
| NCT04495101 |
Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 |
https://ClinicalTrials.gov/show/NCT04495101 |
| NCT04494399 |
IFN Beta-1b and Ribavirin for Covid-19 |
https://ClinicalTrials.gov/show/NCT04494399 |
| NCT04494204 |
Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04494204 |
| NCT04492527 |
Student-delivered Telehealth Program for COVID-19 Education and Health Promotion |
https://ClinicalTrials.gov/show/NCT04492527 |
| NCT04492514 |
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation |
https://ClinicalTrials.gov/show/NCT04492514 |
| NCT04492501 |
Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan |
https://ClinicalTrials.gov/show/NCT04492501 |
| NCT04492410 |
COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID) |
https://ClinicalTrials.gov/show/NCT04492410 |
| NCT04492358 |
Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center |
https://ClinicalTrials.gov/show/NCT04492358 |
| NCT04491994 |
Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression |
https://ClinicalTrials.gov/show/NCT04491994 |
| NCT04490850 |
COVID-19 Seroprevalence Study in French Guiana |
https://ClinicalTrials.gov/show/NCT04490850 |
| NCT04492475 |
Adaptive COVID-19 Treatment Trial 3 (ACTT-3) |
https://ClinicalTrials.gov/show/NCT04492475 |
| NCT04494984 |
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. |
https://ClinicalTrials.gov/show/NCT04494984 |
| NCT04494867 |
Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04494867 |
| NCT04494646 |
BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04494646 |
| NCT04493359 |
Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 |
https://ClinicalTrials.gov/show/NCT04493359 |
| NCT04535791 |
Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04535791 |
| NCT04495816 |
COVID-19 Anosmia Study |
https://ClinicalTrials.gov/show/NCT04495816 |
| NCT04495842 |
The Effect of Aromatherapy on COVID-19-induced Anxiety |
https://ClinicalTrials.gov/show/NCT04495842 |
| NCT04525378 |
MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04525378 |
| NCT04500366 |
GERAS Frailty Rehabilitation at Home During COVID-19 |
https://ClinicalTrials.gov/show/NCT04500366 |
| NCT04498377 |
Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04498377 |
| NCT04497987 |
A Study of LY3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff |
https://ClinicalTrials.gov/show/NCT04497987 |
| NCT04497454 |
Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04497454 |
| NCT04497298 |
Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04497298 |
| NCT04505722 |
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants |
https://ClinicalTrials.gov/show/NCT04505722 |
| NCT04497649 |
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients |
https://ClinicalTrials.gov/show/NCT04497649 |
| NCT04502056 |
Covid-19 Messaging to Underserved Communities - 2nd Experiment |
https://ClinicalTrials.gov/show/NCT04502056 |
| NCT04497415 |
The COVID-19 and Healthcare Workers: An Active Intervention |
https://ClinicalTrials.gov/show/NCT04497415 |
| NCT04526054 |
Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04526054 |
| NCT04510207 |
A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above |
https://ClinicalTrials.gov/show/NCT04510207 |
| NCT04501978 |
ACTIV-3: Therapeutics for Inpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04501978 |
| NCT04501965 |
Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04501965 |
| NCT04498442 |
A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls |
https://ClinicalTrials.gov/show/NCT04498442 |
| NCT04498273 |
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 |
https://ClinicalTrials.gov/show/NCT04498273 |
| NCT04497272 |
Assesment of the Metabolomic Signature in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04497272 |
| NCT04498247 |
A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001) |
https://ClinicalTrials.gov/show/NCT04498247 |
| NCT04631380 |
Prayer in Commbate to Corona Virus - Covid -19 |
https://ClinicalTrials.gov/show/NCT04631380 |
| NCT04504877 |
Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 |
https://ClinicalTrials.gov/show/NCT04504877 |
| NCT04502667 |
Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19 |
https://ClinicalTrials.gov/show/NCT04502667 |
| NCT04502472 |
Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma |
https://ClinicalTrials.gov/show/NCT04502472 |
| NCT04502342 |
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04502342 |
| NCT04501445 |
Psychological Symptoms and Families of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04501445 |
| NCT04500418 |
Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04500418 |
| NCT04500132 |
To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia |
https://ClinicalTrials.gov/show/NCT04500132 |
| NCT04504734 |
Bucillamine in Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04504734 |
| NCT04534790 |
Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04534790 |
| NCT04508439 |
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04508439 |
| NCT04501783 |
Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04501783 |
| NCT04501458 |
Western Kenya Integrated COVID-19 Response |
https://ClinicalTrials.gov/show/NCT04501458 |
| NCT04575610 |
IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC) |
https://ClinicalTrials.gov/show/NCT04575610 |
| NCT04504032 |
A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19) |
https://ClinicalTrials.gov/show/NCT04504032 |
| NCT04501952 |
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting |
https://ClinicalTrials.gov/show/NCT04501952 |
| NCT04527471 |
Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04527471 |
| NCT04513158 |
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04513158 |
| NCT04505774 |
Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4) |
https://ClinicalTrials.gov/show/NCT04505774 |
| NCT04505592 |
Tenecteplase in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04505592 |
| NCT04504240 |
Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04504240 |
| NCT04522492 |
Impact of COVID-19 on Mental Health of Patients With Skin Picking |
https://ClinicalTrials.gov/show/NCT04522492 |
| NCT04511650 |
A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04511650 |
| NCT04508075 |
Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine |
https://ClinicalTrials.gov/show/NCT04508075 |
| NCT04507256 |
AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04507256 |
| NCT04506268 |
COVID-19 SAFE Enrollment |
https://ClinicalTrials.gov/show/NCT04506268 |
| NCT04509999 |
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04509999 |
| NCT04511819 |
Losmapimod Safety and Efficacy in COVID-19 |
https://ClinicalTrials.gov/show/NCT04511819 |
| NCT04516915 |
IMU-838 and Oseltamivir in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04516915 |
| NCT04513470 |
Allocetra-OTS in COVID-19 |
https://ClinicalTrials.gov/show/NCT04513470 |
| NCT04508868 |
Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 |
https://ClinicalTrials.gov/show/NCT04508868 |
| NCT04508023 |
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04508023 |
| NCT04581018 |
An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04581018 |
| NCT04527575 |
Study of the Safety, Reactogenicity and Immunogenicity of “EpiVacCorona” Vaccine for the Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04527575 |
| NCT04514705 |
Characteristics in Post Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04514705 |
| NCT04512079 |
FREEDOM COVID-19 Anticoagulation Strategy |
https://ClinicalTrials.gov/show/NCT04512079 |
| NCT04512027 |
Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support. |
https://ClinicalTrials.gov/show/NCT04512027 |
| NCT04510662 |
Telmisartan in Respiratory Failure Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04510662 |
| NCT04510493 |
Canakinumab in Patients With COVID-19 and Type 2 Diabetes |
https://ClinicalTrials.gov/show/NCT04510493 |
| NCT04509973 |
Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia |
https://ClinicalTrials.gov/show/NCT04509973 |
| NCT04509947 |
A Study of Ad26.COV2.S in Adults (COVID-19) |
https://ClinicalTrials.gov/show/NCT04509947 |
| NCT04522089 |
A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine |
https://ClinicalTrials.gov/show/NCT04522089 |
| NCT04519216 |
Breastfeeding Education in the Time of COVID-19 |
https://ClinicalTrials.gov/show/NCT04519216 |
| NCT04516811 |
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04516811 |
| NCT04513184 |
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04513184 |
| NCT04511949 |
COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04511949 |
| NCT04516564 |
A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04516564 |
| NCT04515147 |
A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 |
https://ClinicalTrials.gov/show/NCT04515147 |
| NCT04540120 |
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome |
https://ClinicalTrials.gov/show/NCT04540120 |
| NCT04517162 |
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04517162 |
| NCT04517123 |
Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The “PRONE” Study |
https://ClinicalTrials.gov/show/NCT04517123 |
| NCT04516759 |
AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19 |
https://ClinicalTrials.gov/show/NCT04516759 |
| NCT04550351 |
Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old) |
https://ClinicalTrials.gov/show/NCT04550351 |
| NCT04517422 |
Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19 |
https://ClinicalTrials.gov/show/NCT04517422 |
| NCT04516837 |
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19) |
https://ClinicalTrials.gov/show/NCT04516837 |
| NCT04547634 |
Telerehabilitation in Oncology Patients |
https://ClinicalTrials.gov/show/NCT04547634 |
| NCT04541680 |
Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04541680 |
| NCT04540419 |
Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04540419 |
| NCT04530578 |
Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 |
https://ClinicalTrials.gov/show/NCT04530578 |
| NCT04519385 |
Toclizumam Versus Dexamethasone in Severe Covid-19 Cases |
https://ClinicalTrials.gov/show/NCT04519385 |
| NCT04516954 |
Convalescent Plasma for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04516954 |
| NCT04516746 |
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04516746 |
| NCT04518410 |
ACTIV-2: A Study for Outpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04518410 |
| NCT04517396 |
FEnofibRate as a Metabolic INtervention for COVID-19 |
https://ClinicalTrials.gov/show/NCT04517396 |
| NCT04612972 |
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru |
https://ClinicalTrials.gov/show/NCT04612972 |
| NCT04587921 |
Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19 |
https://ClinicalTrials.gov/show/NCT04587921 |
| NCT04527614 |
Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection |
https://ClinicalTrials.gov/show/NCT04527614 |
| NCT04523571 |
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects |
https://ClinicalTrials.gov/show/NCT04523571 |
| NCT04522830 |
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04522830 |
| NCT04519411 |
Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04519411 |
| NCT04519320 |
Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae |
https://ClinicalTrials.gov/show/NCT04519320 |
| NCT04581161 |
Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04581161 |
| NCT04531618 |
Mother-infant Bonding During COVID-19 |
https://ClinicalTrials.gov/show/NCT04531618 |
| NCT04529499 |
Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04529499 |
| NCT04528641 |
GRAd-COV2 Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04528641 |
| NCT04528368 |
Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support |
https://ClinicalTrials.gov/show/NCT04528368 |
| NCT04523831 |
Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection |
https://ClinicalTrials.gov/show/NCT04523831 |
| NCT04522466 |
Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients |
https://ClinicalTrials.gov/show/NCT04522466 |
| NCT04521322 |
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04521322 |
| NCT04523181 |
Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04523181 |
| NCT04530448 |
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization |
https://ClinicalTrials.gov/show/NCT04530448 |
| NCT04524598 |
A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19 |
https://ClinicalTrials.gov/show/NCT04524598 |
| NCT04523246 |
Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents |
https://ClinicalTrials.gov/show/NCT04523246 |
| NCT04523090 |
Catalysing the Containment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04523090 |
| NCT04522817 |
CLBS119 for Repair of COVID-19 Induced Pulmonary Damage |
https://ClinicalTrials.gov/show/NCT04522817 |
| NCT04535167 |
First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19. |
https://ClinicalTrials.gov/show/NCT04535167 |
| NCT04529525 |
Ivermectin to Prevent Hospitalizations in COVID-19 |
https://ClinicalTrials.gov/show/NCT04529525 |
| NCT04526912 |
Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04526912 |
| NCT04525417 |
Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers |
https://ClinicalTrials.gov/show/NCT04525417 |
| NCT04524507 |
COVID-19 Antibody Plasma Research Study in Hospitalized Patients |
https://ClinicalTrials.gov/show/NCT04524507 |
| NCT04552379 |
The Containing Coronavirus Disease 19 (COVID-19) Trial |
https://ClinicalTrials.gov/show/NCT04552379 |
| NCT04568031 |
Study of AZD1222 for the Prevention of COVID-19 in Japan |
https://ClinicalTrials.gov/show/NCT04568031 |
| NCT04526990 |
Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above |
https://ClinicalTrials.gov/show/NCT04526990 |
| NCT04530409 |
Timing of Corticosteroids in COVID-19 |
https://ClinicalTrials.gov/show/NCT04530409 |
| NCT04527354 |
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04527354 |
| NCT04527133 |
An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04527133 |
| NCT04527081 |
Study of COVID-19 DNA Vaccine (AG0302-COVID19) |
https://ClinicalTrials.gov/show/NCT04527081 |
| NCT04537351 |
The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04537351 |
| NCT04530604 |
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04530604 |
| NCT04530435 |
PEP Flute-selfcare in COVID-19 |
https://ClinicalTrials.gov/show/NCT04530435 |
| NCT04530396 |
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04530396 |
| NCT04527562 |
Colchicine in Moderate Symptomatic COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04527562 |
| NCT04559074 |
Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04559074 |
| NCT04554992 |
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019) |
https://ClinicalTrials.gov/show/NCT04554992 |
| NCT04536441 |
Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order |
https://ClinicalTrials.gov/show/NCT04536441 |
| NCT04532931 |
COVID-19 Treatment in South Africa |
https://ClinicalTrials.gov/show/NCT04532931 |
| NCT04531774 |
RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19 |
https://ClinicalTrials.gov/show/NCT04531774 |
| NCT04530617 |
Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients |
https://ClinicalTrials.gov/show/NCT04530617 |
| NCT04530422 |
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment |
https://ClinicalTrials.gov/show/NCT04530422 |
| NCT04530370 |
Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients |
https://ClinicalTrials.gov/show/NCT04530370 |
| NCT04530357 |
Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04530357 |
| NCT04546841 |
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults |
https://ClinicalTrials.gov/show/NCT04546841 |
| NCT04539262 |
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation |
https://ClinicalTrials.gov/show/NCT04539262 |
| NCT04530136 |
Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04530136 |
| NCT04539275 |
COVID-19 (VA CURES-1) |
https://ClinicalTrials.gov/show/NCT04539275 |
| NCT04535700 |
Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19 |
https://ClinicalTrials.gov/show/NCT04535700 |
| NCT04532294 |
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants |
https://ClinicalTrials.gov/show/NCT04532294 |
| NCT04535453 |
A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents |
https://ClinicalTrials.gov/show/NCT04535453 |
| NCT04537663 |
Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults |
https://ClinicalTrials.gov/show/NCT04537663 |
| NCT04533399 |
A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults |
https://ClinicalTrials.gov/show/NCT04533399 |
| NCT04537858 |
Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04537858 |
| NCT04535063 |
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04535063 |
| NCT04542941 |
Assessment of Safety and Efficacy of CCP |
https://ClinicalTrials.gov/show/NCT04542941 |
| NCT04535674 |
Asunercept in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04535674 |
| NCT04536051 |
A Study of a Candidate COVID-19 Vaccine (COV003) |
https://ClinicalTrials.gov/show/NCT04536051 |
| NCT04554264 |
Complicated Grief in ICU in the Aftermath of COVID-19 |
https://ClinicalTrials.gov/show/NCT04554264 |
| NCT04545749 |
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04545749 |
| NCT04537949 |
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04537949 |
| NCT04537208 |
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older |
https://ClinicalTrials.gov/show/NCT04537208 |
| NCT04577534 |
COVID-19: Salvage TOcilizumab as a Rescue Measure |
https://ClinicalTrials.gov/show/NCT04577534 |
| NCT04558463 |
The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19 |
https://ClinicalTrials.gov/show/NCT04558463 |
| NCT04542213 |
Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542213 |
| NCT04539821 |
Virtual Pain Care Management (COVID-19) |
https://ClinicalTrials.gov/show/NCT04539821 |
| NCT04539795 |
COVID-19 Study of Safety and Tolerability of Alvelestat |
https://ClinicalTrials.gov/show/NCT04539795 |
| NCT04569188 |
Convalescent Plasma in COVID-19 Elderly Patients |
https://ClinicalTrials.gov/show/NCT04569188 |
| NCT04542967 |
Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04542967 |
| NCT04542694 |
Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542694 |
| NCT04542421 |
Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19 |
https://ClinicalTrials.gov/show/NCT04542421 |
| NCT04540939 |
Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy |
https://ClinicalTrials.gov/show/NCT04540939 |
| NCT04540185 |
A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 |
https://ClinicalTrials.gov/show/NCT04540185 |
| NCT04545060 |
VIR-7831 for the Early Treatment of COVID-19 in Outpatients |
https://ClinicalTrials.gov/show/NCT04545060 |
| NCT04545541 |
Nebulised Heparin in Patients With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04545541 |
| NCT04542447 |
To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients. |
https://ClinicalTrials.gov/show/NCT04542447 |
| NCT04542408 |
Hamburg Edoxaban for Anticoagulation in COVID-19 Study |
https://ClinicalTrials.gov/show/NCT04542408 |
| NCT04542330 |
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04542330 |
| NCT04587414 |
eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19 |
https://ClinicalTrials.gov/show/NCT04587414 |
| NCT04543760 |
Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04543760 |
| NCT04542993 |
Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy |
https://ClinicalTrials.gov/show/NCT04542993 |
| NCT04542876 |
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04542876 |
| NCT04546581 |
Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) |
https://ClinicalTrials.gov/show/NCT04546581 |
| NCT04561154 |
Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV |
https://ClinicalTrials.gov/show/NCT04561154 |
| NCT04557605 |
Effects of a Face Mask on Oxygenation During Exercise |
https://ClinicalTrials.gov/show/NCT04557605 |
| NCT04552483 |
Effects of Early Use of Nitazoxanide in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04552483 |
| NCT04551339 |
Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 |
https://ClinicalTrials.gov/show/NCT04551339 |
| NCT04549922 |
Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19 |
https://ClinicalTrials.gov/show/NCT04549922 |
| NCT04548531 |
Engaging Patients in Colon Cancer Screening Decisions During COVID-19 |
https://ClinicalTrials.gov/show/NCT04548531 |
| NCT04547660 |
Convalescent Plasma for Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04547660 |
| NCT04547283 |
Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04547283 |
| NCT04549337 |
Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19 |
https://ClinicalTrials.gov/show/NCT04549337 |
| NCT04569266 |
Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU |
https://ClinicalTrials.gov/show/NCT04569266 |
| NCT04550325 |
Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 |
https://ClinicalTrials.gov/show/NCT04550325 |
| NCT04547140 |
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04547140 |
| NCT04547127 |
A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04547127 |
| NCT04546737 |
Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04546737 |
| NCT04661527 |
Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19 |
https://ClinicalTrials.gov/show/NCT04661527 |
| NCT04549376 |
Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo |
https://ClinicalTrials.gov/show/NCT04549376 |
| NCT04548544 |
A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19 |
https://ClinicalTrials.gov/show/NCT04548544 |
| NCT04551781 |
Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis |
https://ClinicalTrials.gov/show/NCT04551781 |
| NCT04558476 |
Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation |
https://ClinicalTrials.gov/show/NCT04558476 |
| NCT04610502 |
Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04610502 |
| NCT04591158 |
COVID-19 and Lung Ultrasound Utility |
https://ClinicalTrials.gov/show/NCT04591158 |
| NCT04565249 |
Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04565249 |
| NCT04553705 |
Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) |
https://ClinicalTrials.gov/show/NCT04553705 |
| NCT04551911 |
Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04551911 |
| NCT04551547 |
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04551547 |
| NCT04552366 |
A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04552366 |
| NCT04559113 |
Methylprednisolone in COVID-19 Patients (Methyl19LGH) |
https://ClinicalTrials.gov/show/NCT04559113 |
| NCT04581915 |
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04581915 |
| NCT04560881 |
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19) |
https://ClinicalTrials.gov/show/NCT04560881 |
| NCT04555213 |
A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04555213 |
| NCT04555148 |
COVIDIG (COVID-19 Hyper-ImmunoGlobulin) |
https://ClinicalTrials.gov/show/NCT04555148 |
| NCT04555096 |
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04555096 |
| NCT04570384 |
Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness |
https://ClinicalTrials.gov/show/NCT04570384 |
| NCT04557046 |
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test |
https://ClinicalTrials.gov/show/NCT04557046 |
| NCT04568564 |
Telerehabilitation in Lung Surgery Patients |
https://ClinicalTrials.gov/show/NCT04568564 |
| NCT04567810 |
Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19) |
https://ClinicalTrials.gov/show/NCT04567810 |
| NCT04563650 |
COVID-19 Serology and Immunosenescence |
https://ClinicalTrials.gov/show/NCT04563650 |
| NCT04558021 |
A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19 |
https://ClinicalTrials.gov/show/NCT04558021 |
| NCT04563065 |
Active Pregnancy Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04563065 |
| NCT04558125 |
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism |
https://ClinicalTrials.gov/show/NCT04558125 |
| NCT04558411 |
Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students |
https://ClinicalTrials.gov/show/NCT04558411 |
| NCT04558372 |
Genosvid Diagnostic Test for Early Detection of COVID-19 |
https://ClinicalTrials.gov/show/NCT04558372 |
| NCT04563702 |
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04563702 |
| NCT04559035 |
Nasal Irrigation to Reduce COVID-19 Morbidity |
https://ClinicalTrials.gov/show/NCT04559035 |
| NCT04569383 |
Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19 |
https://ClinicalTrials.gov/show/NCT04569383 |
| NCT04566770 |
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) |
https://ClinicalTrials.gov/show/NCT04566770 |
| NCT04565665 |
Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome |
https://ClinicalTrials.gov/show/NCT04565665 |
| NCT04563689 |
Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04563689 |
| NCT04561219 |
Nitazoxanide Therapy for Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04561219 |
| NCT04593940 |
Immune Modulators for Treating COVID-19 |
https://ClinicalTrials.gov/show/NCT04593940 |
| NCT04573270 |
Mesenchymal Stem Cells for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04573270 |
| NCT04568525 |
Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs |
https://ClinicalTrials.gov/show/NCT04568525 |
| NCT04565379 |
Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients |
https://ClinicalTrials.gov/show/NCT04565379 |
| NCT04563676 |
Physiopathology and Sequelae of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04563676 |
| NCT04609462 |
High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure. |
https://ClinicalTrials.gov/show/NCT04609462 |
| NCT04576728 |
Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04576728 |
| NCT04568876 |
Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04568876 |
| NCT04567173 |
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04567173 |
| NCT04569786 |
Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001) |
https://ClinicalTrials.gov/show/NCT04569786 |
| NCT04565509 |
Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04565509 |
| NCT04564716 |
Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus |
https://ClinicalTrials.gov/show/NCT04564716 |
| NCT04565197 |
Convalescent Plasma Therapy for COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04565197 |
| NCT04570488 |
Predicting Favorable Outcomes in Hospitalized Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04570488 |
| NCT04569877 |
GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04569877 |
| NCT04567953 |
COVID-19 Tests With Saliva Specimens |
https://ClinicalTrials.gov/show/NCT04567953 |
| NCT04568122 |
Rapid Turnaround, Home-based Saliva Testing for COVID-19 |
https://ClinicalTrials.gov/show/NCT04568122 |
| NCT04570254 |
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04570254 |
| NCT04568356 |
A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests |
https://ClinicalTrials.gov/show/NCT04568356 |
| NCT04583410 |
Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers |
https://ClinicalTrials.gov/show/NCT04583410 |
| NCT04576312 |
Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04576312 |
| NCT04572399 |
UVA Light Device to Treat COVID-19 |
https://ClinicalTrials.gov/show/NCT04572399 |
| NCT04570202 |
Health cAre woRkers exposeD to COVID-19 |
https://ClinicalTrials.gov/show/NCT04570202 |
| NCT04568863 |
Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19 |
https://ClinicalTrials.gov/show/NCT04568863 |
| NCT04568811 |
The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine |
https://ClinicalTrials.gov/show/NCT04568811 |
| NCT04629105 |
Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER) |
https://ClinicalTrials.gov/show/NCT04629105 |
| NCT04577235 |
Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores. |
https://ClinicalTrials.gov/show/NCT04577235 |
| NCT04573361 |
Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain |
https://ClinicalTrials.gov/show/NCT04573361 |
| NCT04573322 |
Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects |
https://ClinicalTrials.gov/show/NCT04573322 |
| NCT04569825 |
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease |
https://ClinicalTrials.gov/show/NCT04569825 |
| NCT04649086 |
Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04649086 |
| NCT04575064 |
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY |
https://ClinicalTrials.gov/show/NCT04575064 |
| NCT04573153 |
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04573153 |
| NCT04575597 |
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) |
https://ClinicalTrials.gov/show/NCT04575597 |
| NCT04575584 |
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) |
https://ClinicalTrials.gov/show/NCT04575584 |
| NCT04582344 |
Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) |
https://ClinicalTrials.gov/show/NCT04582344 |
| NCT04578210 |
Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia |
https://ClinicalTrials.gov/show/NCT04578210 |
| NCT04583189 |
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department |
https://ClinicalTrials.gov/show/NCT04583189 |
| NCT04575038 |
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 |
https://ClinicalTrials.gov/show/NCT04575038 |
| NCT04583449 |
Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04583449 |
| NCT04597034 |
Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04597034 |
| NCT04603781 |
CBD Oil for Reducing Emotional Impact of COVID-19 |
https://ClinicalTrials.gov/show/NCT04603781 |
| NCT04581291 |
The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial |
https://ClinicalTrials.gov/show/NCT04581291 |
| NCT04594330 |
Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04594330 |
| NCT04593641 |
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04593641 |
| NCT04581954 |
Inflammatory Signal Inhibitors for COVID-19 (MATIS) |
https://ClinicalTrials.gov/show/NCT04581954 |
| NCT04589936 |
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care |
https://ClinicalTrials.gov/show/NCT04589936 |
| NCT04584580 |
D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04584580 |
| NCT04582214 |
Oscillation and Lung Expansion Therapy in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04582214 |
| NCT04582201 |
An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing. |
https://ClinicalTrials.gov/show/NCT04582201 |
| NCT04579549 |
Repeat Testing for SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04579549 |
| NCT04578158 |
Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04578158 |
| NCT04579640 |
Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections |
https://ClinicalTrials.gov/show/NCT04579640 |
| NCT04579393 |
Fostamatinib for Hospitalized Adults With COVID-19 |
https://ClinicalTrials.gov/show/NCT04579393 |
| NCT04584567 |
OD-doxy-PNV-COV Old Drug " DOXY " for Prevention of New Virus Virus OD-doxy-PNV |
https://ClinicalTrials.gov/show/NCT04584567 |
| NCT04623671 |
Intravenous Infusion of CAP-1002 in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04623671 |
| NCT04594668 |
Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency |
https://ClinicalTrials.gov/show/NCT04594668 |
| NCT04582318 |
A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19 |
https://ClinicalTrials.gov/show/NCT04582318 |
| NCT04581811 |
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) |
https://ClinicalTrials.gov/show/NCT04581811 |
| NCT04583592 |
Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT) |
https://ClinicalTrials.gov/show/NCT04583592 |
| NCT04600999 |
Clinical Trial of Favipiravir Treatment of Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04600999 |
| NCT04590430 |
Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04590430 |
| NCT04584710 |
A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults |
https://ClinicalTrials.gov/show/NCT04584710 |
| NCT04583995 |
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom |
https://ClinicalTrials.gov/show/NCT04583995 |
| NCT04583969 |
ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04583969 |
| NCT04583956 |
ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04583956 |
| NCT04610541 |
REMdesivir-HU Clinical Study and Severe Covid-19 Patients |
https://ClinicalTrials.gov/show/NCT04610541 |
| NCT04593069 |
The COGCOV Study in ICU Patients |
https://ClinicalTrials.gov/show/NCT04593069 |
| NCT04589949 |
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) |
https://ClinicalTrials.gov/show/NCT04589949 |
| NCT04589117 |
Expressive Writing for COVID-19 Resilience for Parents |
https://ClinicalTrials.gov/show/NCT04589117 |
| NCT04589104 |
Expressive Writing for COVID-19 Resilience |
https://ClinicalTrials.gov/show/NCT04589104 |
| NCT04584593 |
Pilot Study to Detect SARS-CoV-2 Virus in Sperm |
https://ClinicalTrials.gov/show/NCT04584593 |
| NCT04592549 |
This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04592549 |
| NCT04591717 |
Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT04591717 |
| NCT04587219 |
The Study of “Gam-COVID-Vac” Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older |
https://ClinicalTrials.gov/show/NCT04587219 |
| NCT04588480 |
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults |
https://ClinicalTrials.gov/show/NCT04588480 |
| NCT04598594 |
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients |
https://ClinicalTrials.gov/show/NCT04598594 |
| NCT04592354 |
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors |
https://ClinicalTrials.gov/show/NCT04592354 |
| NCT04591600 |
Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04591600 |
| NCT04590053 |
Allocetra-OTS in COVID-19, Phase II |
https://ClinicalTrials.gov/show/NCT04590053 |
| NCT04602000 |
To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19 |
https://ClinicalTrials.gov/show/NCT04602000 |
| NCT04594343 |
Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04594343 |
| NCT04648800 |
Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland |
https://ClinicalTrials.gov/show/NCT04648800 |
| NCT04609371 |
PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics |
https://ClinicalTrials.gov/show/NCT04609371 |
| NCT04602312 |
How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample) |
https://ClinicalTrials.gov/show/NCT04602312 |
| NCT04602286 |
How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample) |
https://ClinicalTrials.gov/show/NCT04602286 |
| NCT04597047 |
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test |
https://ClinicalTrials.gov/show/NCT04597047 |
| NCT04596085 |
Study to Evaluate Efficacy and Safety of “VIRACIDE” IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04596085 |
| NCT04604977 |
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine |
https://ClinicalTrials.gov/show/NCT04604977 |
| NCT04603924 |
Study of Niclosamide in Moderate Hospitalized Coronavirus-19 (COVID-19) Patients |
https://ClinicalTrials.gov/show/NCT04603924 |
| NCT04600440 |
Convalescent Plasma in the Treatment of Covid-19 |
https://ClinicalTrials.gov/show/NCT04600440 |
| NCT04598581 |
Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19 |
https://ClinicalTrials.gov/show/NCT04598581 |
| NCT04596839 |
Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04596839 |
| NCT04603794 |
Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19 |
https://ClinicalTrials.gov/show/NCT04603794 |
| NCT04603729 |
Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease |
https://ClinicalTrials.gov/show/NCT04603729 |
| NCT04602871 |
Early Detection of COVID-19 Using Breath Analysis - Feasibility Study |
https://ClinicalTrials.gov/show/NCT04602871 |
| NCT04602442 |
Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia |
https://ClinicalTrials.gov/show/NCT04602442 |
| NCT04601077 |
The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans |
https://ClinicalTrials.gov/show/NCT04601077 |
| NCT04609423 |
Cod Liver Oil for Covid-19 Prevention Study |
https://ClinicalTrials.gov/show/NCT04609423 |
| NCT04599959 |
COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR |
https://ClinicalTrials.gov/show/NCT04599959 |
| NCT04602507 |
Ivermectin in Adults With Severe COVID-19. |
https://ClinicalTrials.gov/show/NCT04602507 |
| NCT04625985 |
Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2. |
https://ClinicalTrials.gov/show/NCT04625985 |
| NCT04604327 |
Comparison of Two Different Doses of Bemiparin in COVID-19 |
https://ClinicalTrials.gov/show/NCT04604327 |
| NCT04602832 |
Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04602832 |
| NCT04610567 |
Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19) |
https://ClinicalTrials.gov/show/NCT04610567 |
| NCT04615429 |
Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19 |
https://ClinicalTrials.gov/show/NCT04615429 |
| NCT04613271 |
Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia |
https://ClinicalTrials.gov/show/NCT04613271 |
| NCT04603963 |
Inspiratory Muscle Training in Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04603963 |
| NCT04632706 |
Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19 |
https://ClinicalTrials.gov/show/NCT04632706 |
| NCT04615416 |
Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04615416 |
| NCT04613310 |
PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) |
https://ClinicalTrials.gov/show/NCT04613310 |
| NCT04610801 |
Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2 |
https://ClinicalTrials.gov/show/NCT04610801 |
| NCT04609722 |
Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04609722 |
| NCT04608305 |
Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine |
https://ClinicalTrials.gov/show/NCT04608305 |
| NCT04604184 |
ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 |
https://ClinicalTrials.gov/show/NCT04604184 |
| NCT04605588 |
A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19 |
https://ClinicalTrials.gov/show/NCT04605588 |
| NCT04606563 |
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? |
https://ClinicalTrials.gov/show/NCT04606563 |
| NCT04606784 |
Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress |
https://ClinicalTrials.gov/show/NCT04606784 |
| NCT04653831 |
Treatment With Pirfenidone for COVID-19 Related Severe ARDS |
https://ClinicalTrials.gov/show/NCT04653831 |
| NCT04608097 |
Understanding Reactions to Emotional Material in the Media During COVID-19 |
https://ClinicalTrials.gov/show/NCT04608097 |
| NCT04607928 |
Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19 |
https://ClinicalTrials.gov/show/NCT04607928 |
| NCT04609969 |
Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test |
https://ClinicalTrials.gov/show/NCT04609969 |
| NCT04608266 |
CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients |
https://ClinicalTrials.gov/show/NCT04608266 |
| NCT04615741 |
Finding Wellness in the Pandemic |
https://ClinicalTrials.gov/show/NCT04615741 |
| NCT04615052 |
Home-based Exercise in COVID-19 Survivors |
https://ClinicalTrials.gov/show/NCT04615052 |
| NCT04611256 |
Mesenchymal Stem Cells in Patients Diagnosed With COVID-19 |
https://ClinicalTrials.gov/show/NCT04611256 |
| NCT04627467 |
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) |
https://ClinicalTrials.gov/show/NCT04627467 |
| NCT04613050 |
Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients |
https://ClinicalTrials.gov/show/NCT04613050 |
| NCT04615975 |
Ketogenic Diet as Protective Factor During COVID-19 |
https://ClinicalTrials.gov/show/NCT04615975 |
| NCT04644705 |
Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat |
https://ClinicalTrials.gov/show/NCT04644705 |
| NCT04616846 |
Thromboembolic Risk Screening in Patients With Cancer and COVID-19 |
https://ClinicalTrials.gov/show/NCT04616846 |
| NCT04615936 |
Nasal Photodisinfection COVID Proof of Concept Study |
https://ClinicalTrials.gov/show/NCT04615936 |
| NCT04614883 |
Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04614883 |
| NCT04614025 |
Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19 |
https://ClinicalTrials.gov/show/NCT04614025 |
| NCT04614012 |
Hyperimmune Plasma for Patients With COVID-19 |
https://ClinicalTrials.gov/show/NCT04614012 |
| NCT04613297 |
HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment |
https://ClinicalTrials.gov/show/NCT04613297 |
| NCT04614948 |
A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04614948 |
| NCT04629157 |
The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19 |
https://ClinicalTrials.gov/show/NCT04629157 |
| NCT04622826 |
plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients |
https://ClinicalTrials.gov/show/NCT04622826 |
| NCT04621123 |
Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04621123 |
| NCT04620798 |
Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students |
https://ClinicalTrials.gov/show/NCT04620798 |
| NCT04619290 |
Outpatient Treatment With CoVid-19 With Prexablu |
https://ClinicalTrials.gov/show/NCT04619290 |
| NCT04617483 |
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults |
https://ClinicalTrials.gov/show/NCT04617483 |
| NCT04632537 |
BCG Vaccination to Prevent COVID-19 |
https://ClinicalTrials.gov/show/NCT04632537 |
| NCT04639466 |
A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19 |
https://ClinicalTrials.gov/show/NCT04639466 |
| NCT04635618 |
Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04635618 |
| NCT04632082 |
Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04632082 |
| NCT04625114 |
The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden |
https://ClinicalTrials.gov/show/NCT04625114 |
| NCT04623021 |
A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia |
https://ClinicalTrials.gov/show/NCT04623021 |
| NCT04619680 |
The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19 |
https://ClinicalTrials.gov/show/NCT04619680 |
| NCT04637477 |
Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study |
https://ClinicalTrials.gov/show/NCT04637477 |
| NCT04633772 |
Use of Angiotensin-(1-7) in COVID-19 |
https://ClinicalTrials.gov/show/NCT04633772 |
| NCT04622891 |
Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04622891 |
| NCT04621903 |
A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04621903 |
| NCT04621058 |
Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19. |
https://ClinicalTrials.gov/show/NCT04621058 |
| NCT04641481 |
An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers |
https://ClinicalTrials.gov/show/NCT04641481 |
| NCT04635943 |
Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 |
https://ClinicalTrials.gov/show/NCT04635943 |
| NCT04622865 |
Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04622865 |
| NCT04657497 |
A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) |
https://ClinicalTrials.gov/show/NCT04657497 |
| NCT04625972 |
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults |
https://ClinicalTrials.gov/show/NCT04625972 |
| NCT04625725 |
Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. |
https://ClinicalTrials.gov/show/NCT04625725 |
| NCT04634903 |
Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19 |
https://ClinicalTrials.gov/show/NCT04634903 |
| NCT04643964 |
Brief Video Interventions for Depression |
https://ClinicalTrials.gov/show/NCT04643964 |
| NCT04636697 |
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults |
https://ClinicalTrials.gov/show/NCT04636697 |
| NCT04630054 |
Face Masks to Reduce COVID-19 in Bangladesh |
https://ClinicalTrials.gov/show/NCT04630054 |
| NCT04629989 |
Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19 |
https://ClinicalTrials.gov/show/NCT04629989 |
| NCT04646044 |
A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 |
https://ClinicalTrials.gov/show/NCT04646044 |
| NCT04635241 |
Inhaled Heparin for Hospitalised COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04635241 |
| NCT04632719 |
The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19 |
https://ClinicalTrials.gov/show/NCT04632719 |
| NCT04646109 |
Ivermectin for Severe COVID-19 Management |
https://ClinicalTrials.gov/show/NCT04646109 |
| NCT04642326 |
Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis |
https://ClinicalTrials.gov/show/NCT04642326 |
| NCT04639375 |
Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) |
https://ClinicalTrials.gov/show/NCT04639375 |
| NCT04632602 |
Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure |
https://ClinicalTrials.gov/show/NCT04632602 |
| NCT04637867 |
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO) |
https://ClinicalTrials.gov/show/NCT04637867 |
| NCT04637828 |
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection |
https://ClinicalTrials.gov/show/NCT04637828 |
| NCT04636086 |
Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04636086 |
| NCT04634799 |
Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 |
https://ClinicalTrials.gov/show/NCT04634799 |
| NCT04636333 |
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell) |
https://ClinicalTrials.gov/show/NCT04636333 |
| NCT04634409 |
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness |
https://ClinicalTrials.gov/show/NCT04634409 |
| NCT04634318 |
Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID) |
https://ClinicalTrials.gov/show/NCT04634318 |
| NCT04636320 |
Prevalence of Myocardial Scars on CMR After COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04636320 |
| NCT04638673 |
NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis |
https://ClinicalTrials.gov/show/NCT04638673 |
| NCT04640402 |
A Phase â…¡ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells) |
https://ClinicalTrials.gov/show/NCT04640402 |
| NCT04639349 |
Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID |
https://ClinicalTrials.gov/show/NCT04639349 |
| NCT04640038 |
Contrast Enhanced Ultrasound in COVID-19 |
https://ClinicalTrials.gov/show/NCT04640038 |
| NCT04640168 |
Adaptive COVID-19 Treatment Trial 4 (ACTT-4) |
https://ClinicalTrials.gov/show/NCT04640168 |
| NCT04651790 |
Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against COVID-19 in High Infection Risk Adults |
https://ClinicalTrials.gov/show/NCT04651790 |
| NCT04642040 |
Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia |
https://ClinicalTrials.gov/show/NCT04642040 |
| NCT04646655 |
Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 |
https://ClinicalTrials.gov/show/NCT04646655 |
| NCT04641858 |
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04641858 |
| NCT04644172 |
Improving Thinking in Everyday Life After Covid-19 |
https://ClinicalTrials.gov/show/NCT04644172 |
| NCT04642638 |
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure |
https://ClinicalTrials.gov/show/NCT04642638 |
| NCT04643691 |
Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS |
https://ClinicalTrials.gov/show/NCT04643691 |
| NCT04643561 |
Using Travelan to Boost Immune Response in Vitro to COVID-19 |
https://ClinicalTrials.gov/show/NCT04643561 |
| NCT04643678 |
Anakinra in the Management of COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04643678 |
| NCT04655625 |
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19) |
https://ClinicalTrials.gov/show/NCT04655625 |
| NCT04647695 |
IFN-beta 1b and Remdesivir for COVID19 |
https://ClinicalTrials.gov/show/NCT04647695 |
| NCT04649736 |
Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients |
https://ClinicalTrials.gov/show/NCT04649736 |
| NCT04659486 |
Adolescents With COVID-19/MIS-C at HCFMUSP |
https://ClinicalTrials.gov/show/NCT04659486 |
| NCT04663737 |
Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 |
https://ClinicalTrials.gov/show/NCT04663737 |
| NCT04652674 |
Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial |
https://ClinicalTrials.gov/show/NCT04652674 |
| NCT04652648 |
Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts |
https://ClinicalTrials.gov/show/NCT04652648 |
| NCT04657809 |
Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia |
https://ClinicalTrials.gov/show/NCT04657809 |
| NCT04658979 |
Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study |
https://ClinicalTrials.gov/show/NCT04658979 |
| NCT04654481 |
Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04654481 |
| NCT04662021 |
Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety |
https://ClinicalTrials.gov/show/NCT04662021 |
| NCT04656626 |
Brief Mindfulness Based Intervention to Improve Psychological Wellbeing |
https://ClinicalTrials.gov/show/NCT04656626 |
| NCT04658433 |
The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People |
https://ClinicalTrials.gov/show/NCT04658433 |
| NCT04657484 |
Comparison of Two Corticosteroid Regimens for Post-COVID Diffuse Lung Disease |
https://ClinicalTrials.gov/show/NCT04657484 |
| NCT04659772 |
A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection |
https://ClinicalTrials.gov/show/NCT04659772 |
| NCT04664010 |
Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19) |
https://ClinicalTrials.gov/show/NCT04664010 |
| NCT04661410 |
Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic |
https://ClinicalTrials.gov/show/NCT04661410 |
| NCT04659941 |
Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers |
https://ClinicalTrials.gov/show/NCT04659941 |
| NCT04665193 |
An Approach to Screening for COVID-19 at Vancouver Airport |
https://ClinicalTrials.gov/show/NCT04665193 |
| NCT04662684 |
Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial |
https://ClinicalTrials.gov/show/NCT04662684 |
| NCT04662671 |
Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19 |
https://ClinicalTrials.gov/show/NCT04662671 |
| NCT04661930 |
Fenofibrate for Patients With COVID-19 Requiring Hospitalization |
https://ClinicalTrials.gov/show/NCT04661930 |
| NCT04661839 |
Phase 1 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered as a Single Dose or a Repeat Dose in Healthy Adults |
https://ClinicalTrials.gov/show/NCT04661839 |
